Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
42868691	s-t4-vdi	pmol/l (pmol/l)	1343	1876	0.16%
42868691	s-t4-vdi	— (—)	302	402	100.00%	Distribution not available
42868691	s-t4-vdi	pmol/l____ (pmol/l)	40	50	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Disorders of the thyroid gland

742

544

8.94

307.65

1.5

1.2

15.01

13.75

pmol/l

3.11

627

458

Hypothyroidism, other/unspecified

698

518

8.95

307.65

1.5

1.2

14.64

13.76

pmol/l

2.51

585

438

Thyrotoxicosis, other and/or unspecified

266

154

17.71

307.65

1.7

1.2

17.47

14.05

pmol/l

4.11

240

129

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

433

455

9.73

307.65

1.8

1.3

16.00

14.45

pmol/l

2.31

387

369

Hypothyreosis and Thyroxine purchase for inclusion criteria

716

656

7.22

307.65

1.5

1.3

14.70

14.37

pmol/l

0.43

599

560

Hypothyroidism (congenital or acquired)

281

28.54

266.12

1.6

1.2

14.44

13.97

pmol/l

0.29

239

Hypothyroidism, levothyroxine purchases

278

28.78

264.03

1.6

1.2

14.49

14.07

pmol/l

0.26

238

Hypothyroidism and >3 levothyroxin purchases

278

28.78

264.03

1.6

1.2

14.49

14.07

pmol/l

0.26

238

Hypothyroidism, strict autoimmune

456

421

7.16

250.82

1.4

1.2

14.21

13.88

pmol/l

0.60

366

357

Thyrotoxicosis

306

357

8.76

241.09

1.7

1.4

17.23

14.41

pmol/l

3.85

273

291

Disorders of thyroid, IBD co-morbidities

250

111

15.74

226.37

1.7

1.3

16.95

13.15

pmol/l

4.40

226

Used for control exclusion in common control thyroid runs

536

443

6.14

225.98

1.6

1.2

14.90

13.92

pmol/l

1.70

456

374

Hypothyroidism, strict autoimmune, 3 medication purchases required

494

627

5.33

210.33

1.4

1.3

14.35

14.38

pmol/l

0.04

391

536

Endocrine, nutritional and metabolic diseases

402

255

8.01

207.33

1.5

1.2

14.71

13.79

pmol/l

1.13

346

217

Thyrotoxicosis with diffuse goitre

162

100

16.57

192.35

1.7

1.2

15.89

13.88

pmol/l

2.62

145

Carbimazole or st.post thyroidectomy, condition for graves disease

242

316

7.82

173.78

1.8

1.5

17.48

14.25

pmol/l

3.54

217

262

Postprocedural endocrine and metabolic disorders, not elsewhere classified

175

170

10.57

158.38

1.9

1.4

16.21

14.80

pmol/l

1.33

158

144

Other metabolic disorders

178

179

10.20

157.14

1.9

1.4

16.23

14.76

pmol/l

1.47

161

152

Hypothyroidism, drug reimbursement

140

24.83

152.40

1.9

1.2

15.17

13.95

pmol/l

1.19

126

Benign thyroid growths and nodules

193

239

7.58

131.60

1.6

1.2

15.20

14.51

pmol/l

0.98

166

191

Exclusions for E4_PCOS_BROAD

180

247

7.42

123.66

1.7

1.5

13.39

14.90

pmol/l

2.06

159

207

Thyroiditis, ILD-related definition

149

176

8.68

116.49

1.6

15.48

14.58

pmol/l

0.37

130

146

Disorders of other endocrine glands

287

684

4.16

105.35

1.6

1.4

14.27

15.16

pmol/l

1.36

249

561

Graves disease, strict definition

128

170

7.72

90.82

1.6

1.5

15.89

14.39

pmol/l

1.41

114

141

Autoimmune diseases

454

743

3.11

88.33

1.4

14.62

14.51

pmol/l

0.10

377

643

Non-invasive ventilation

146

197

6.45

83.70

1.6

1.5

14.95

14.09

pmol/l

0.40

134

165

Hypopituitarism

11.13

83.52

1.8

1.5

12.18

15.89

pmol/l

2.12

Autoimmune hyperthyroidism

13.30

82.95

1.6

1.7

15.81

14.04

pmol/l

1.47

Metabolic disorders

411

842

2.94

77.31

1.6

1.3

15.58

14.41

pmol/l

1.42

356

698

Anaemias

12.04

75.84

1.4

1.2

15.99

13.81

pmol/l

0.71

Mood disorders, excluding more controls

389

829

2.77

65.54

1.4

13.31

15.29

pmol/l

7.06

313

717

Medical observation and evaluation for suspected diseases and conditions

268

385

3.57

64.15

1.5

1.4

14.74

14.92

pmol/l

0.13

214

334

Anxiety disorders, excluding more controls

351

805

2.80

61.86

1.5

1.4

13.86

15.30

pmol/l

3.66

278

698

Nontoxic multinodular goitre

140

6.85

61.27

1.6

1.3

14.93

14.92

pmol/l

0.01

113

Mood [affective] disorders

434

1128

2.47

60.36

1.4

13.32

15.21

pmol/l

8.86

351

967

Mood disorders

434

1131

2.46

59.79

1.4

13.32

15.20

pmol/l

8.82

351

970

Depression

409

1104

2.49

58.20

1.4

13.38

15.22

pmol/l

8.06

334

947

Headache

294

797

2.86

57.07

1.4

13.81

14.55

pmol/l

1.70

250

678

Anxiety (asthma-related co-morbidities)

285

748

2.91

56.71

1.5

1.4

13.80

14.98

pmol/l

2.45

229

649

Depression medications

104

8.61

56.47

1.5

1.2

13.20

14.16

pmol/l

0.89

Benzodiazepine use

415

1170

2.40

55.11

1.5

1.4

14.01

14.91

pmol/l

2.30

322

1016

Anxiety disorders

383

1093

2.41

51.59

1.5

1.4

13.75

14.94

pmol/l

3.53

308

939

Neurotic, stress-related and somatoform disorders

381

1090

2.42

51.56

1.5

1.4

13.74

14.93

pmol/l

3.48

306

937

All anxiety disorders

290

837

2.70

50.67

1.5

1.4

13.82

14.77

pmol/l

1.88

234

728

Heart failure, not strict

278

683

2.75

48.28

1.3

1.5

17.00

14.55

pmol/l

2.50

236

570

Abnormalities of breathing

354

823

2.47

47.67

1.4

15.31

14.38

pmol/l

1.00

301

707

Malaise and fatigue

214

566

2.99

45.23

1.4

1.5

15.60

14.87

pmol/l

0.40

180

474

Other disorders of fluid, electrolyte and acid-base balance

142

358

3.76

45.11

1.3

1.4

17.59

15.71

pmol/l

0.77

111

295

Autoimmune diseases related-to ILD

343

1240

2.32

44.39

1.5

1.4

14.87

14.62

pmol/l

0.19

290

1047

General examination and investigation of persons without complaint and reported diagnosis

227

384

3.08

44.20

1.4

14.65

14.92

pmol/l

0.16

181

333

Other antidepressants

364

781

2.39

44.17

1.4

14.11

15.50

pmol/l

3.47

290

682

Abnormal results of function studies

116

6.39

43.97

1.6

1.5

16.48

14.49

pmol/l

0.56

Antihypertensive medication - note that there are other indications

237

435

2.86

40.90

1.5

1.4

14.39

13.32

pmol/l

1.34

203

375

Benign neoplasm: Pituitary gland, craniopharyngeal duct

8.12

40.16

1.6

1.5

14.26

14.23

pmol/l

0.01

Other anxiety disorders

212

657

2.76

39.61

1.5

1.4

13.89

14.56

pmol/l

0.89

169

576

Hypo-osmolality and hyponatraemia

198

4.65

39.30

1.4

16.40

16.08

pmol/l

0.20

157

Unspecified mental disorder

180

624

2.90

38.31

1.4

1.5

13.14

15.02

pmol/l

4.44

147

527

Recurrent or chronic depression

161

345

3.25

37.76

1.4

1.5

13.05

15.63

pmol/l

3.57

134

300

Bipolar affective disorders

105

265

3.99

36.99

1.3

1.6

12.68

15.39

pmol/l

3.36

227

Schizophrenia or delusion, excluding more controls

124

347

3.55

36.79

1.5

13.27

15.50

pmol/l

3.14

302

Any mental disorder

363

834

2.18

36.12

1.4

14.11

15.32

pmol/l

2.82

294

722

General symptoms and signs

362

839

2.17

35.31

1.4

14.71

14.56

pmol/l

0.11

306

717

Dyspnoea

331

1116

2.15

34.71

1.4

15.81

14.35

pmol/l

1.89

278

931

Kela-code for severe mental illness

158

549

2.89

33.59

1.4

1.5

12.92

15.04

pmol/l

4.73

128

455

Any reimbursement code in KELA

207

377

2.76

33.32

1.5

1.3

14.72

13.50

pmol/l

1.40

178

326

Depression or dysthymia

213

437

2.67

33.21

1.4

14.22

15.85

pmol/l

2.15

172

378

Implicit Sepsis

273

891

2.26

32.75

1.4

1.5

16.68

14.55

pmol/l

1.87

217

753

Heart failure,strict

168

409

2.88

32.32

1.4

1.5

19.00

15.14

pmol/l

2.34

139

337

Other CVD (FINNGEN)

6.56

32.18

1.4

1.5

18.87

14.27

pmol/l

1.19

Personality disorders, excluding more controls

108

308

3.52

31.79

1.4

1.5

12.56

14.75

pmol/l

2.84

272

Nontoxic goitre/thyroid nodule

142

482

2.97

31.56

1.6

1.4

14.62

15.30

pmol/l

1.06

121

396

Pain in throat and chest

297

802

2.20

31.51

1.5

1.4

15.12

14.44

pmol/l

0.54

253

687

Other nutritional deficiencies

265

1103

2.20

31.15

1.3

1.4

13.25

14.72

pmol/l

4.33

221

934

Sleep disorders (combined)

381

994

2.01

31.02

1.4

14.38

15.07

pmol/l

1.41

320

837

Selective serotonin reuptake inhibitors

319

783

2.12

30.04

1.4

13.70

15.50

pmol/l

5.36

260

684

Low back pain

281

878

2.17

29.79

1.5

1.4

14.11

14.67

pmol/l

0.81

227

758

Heart failure and antihypertensive medication

117

4.57

29.69

1.4

1.5

20.51

13.85

pmol/l

2.02

Examination and observation for other reasons

182

383

2.69

29.14

1.5

1.4

15.90

14.91

pmol/l

0.51

150

332

Disorders of parathyroid gland

100

286

3.48

28.88

1.6

1.5

15.84

15.82

pmol/l

0.01

230

Diabetes mellitus

359

1051

1.98

28.87

1.5

1.4

14.68

14.64

pmol/l

0.04

308

881

Other headache syndromes

175

693

2.53

28.67

1.5

1.4

14.32

14.89

pmol/l

0.46

142

571

Neurological diseases

291

676

2.17

28.56

1.5

1.4

14.33

14.82

pmol/l

0.69

245

577

Osteoporosis

120

356

3.12

28.52

1.5

16.42

15.84

pmol/l

0.54

288

Neurological diseases, wide definition

108

144

3.78

28.01

1.5

1.3

13.87

13.32

pmol/l

0.58

124

Symptoms and signs involving cognition, perception, emotional state and behaviour

335

1135

1.98

27.90

1.4

14.54

14.60

pmol/l

0.05

275

963

Diabetes, varying definitions

355

1053

1.96

27.88

1.5

1.4

14.71

14.63

pmol/l

0.07

305

882

Abnormalities of heart beat

140

489

2.79

27.73

1.4

14.38

14.60

pmol/l

0.17

116

408

Substance abuse, excluding more controls

174

576

2.53

27.60

1.3

1.4

14.01

15.41

pmol/l

1.92

135

506

Implicit Sepsis, including avohilmo

284

980

2.07

27.41

1.4

1.5

16.44

14.45

pmol/l

1.80

228

829

Type 2 diabetes

339

995

1.98

27.31

1.4

14.68

14.73

pmol/l

0.04

290

830

Psychiatric diseases

294

701

2.10

26.91

1.4

14.29

15.45

pmol/l

2.19

242

603

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

110

349

3.13

26.85

1.3

1.4

12.51

14.71

pmol/l

3.31

308

Exclusions for E4_PCOS_CONSORTIUM

297

911

2.04

26.59

1.4

13.60

14.49

pmol/l

2.23

247

767

Other functional intestinal disorders

180

677

2.42

26.53

1.4

14.73

15.19

pmol/l

0.51

150

573

Nonorganic sleeping disorders, excluding more controls

263

3.48

26.45

1.5

14.04

14.81

pmol/l

0.63

226

Other special examinations and investigations of persons without complaint or reported diagnosis

191

385

2.52

26.16

1.5

1.4

14.15

14.92

pmol/l

0.96

165

334

Cardiac arrhythmias

206

567

2.33

25.80

1.5

16.24

13.68

pmol/l

2.70

178

480

Diabetes medication

358

1107

1.89

25.55

1.5

1.4

14.31

14.82

pmol/l

0.86

299

933

Symptoms and signs involving the circulatory and respiratory systems

325

827

1.97

25.15

1.5

1.4

14.86

14.37

pmol/l

0.38

271

711

Benign neoplasm of other and unspecified endocrine glands

176

4.01

24.94

1.5

14.66

15.36

pmol/l

0.40

151

Obesity due to excess calories

190

836

2.28

24.92

1.4

13.11

14.66

pmol/l

3.72

158

709

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

229

935

2.14

24.91

1.5

1.4

15.94

14.86

pmol/l

0.75

189

780

Migraine

204

706

2.26

24.75

1.5

1.4

13.58

14.45

pmol/l

1.54

175

592

Other arrhythmias

221

756

2.19

24.72

1.5

1.4

16.17

14.04

pmol/l

2.34

190

637

Adrenocortical insufficiency

7.71

24.27

1.6

1.5

14.99

15.04

pmol/l

0.02

Condition for Implicit Sepsis (Organ dysfunction codes)

287

1008

1.98

24.20

1.3

1.5

16.34

14.47

pmol/l

1.68

234

849

Behavioural syndromes associated with physiological disturbances and physical factors

332

1195

1.88

24.19

1.4

13.94

14.93

pmol/l

2.65

280

1011

Asthma, excluding more controls

245

585

2.15

24.00

1.4

1.5

14.47

14.19

pmol/l

0.24

211

497

Heart failure, strict

176

511

2.40

23.95

1.4

1.5

18.84

15.23

pmol/l

2.25

145

419

Cardiovascular diseases (excluding rheumatic etc)

228

597

2.19

23.95

1.5

1.4

14.63

13.39

pmol/l

1.69

199

510

Other reaction to severe stress, and adjustment disorders

143

566

2.53

23.70

1.5

1.4

13.47

14.54

pmol/l

1.38

112

497

Other soft tissue disorders, not elsewhere classified

314

928

1.93

23.59

1.4

14.63

pmol/l

0.00

269

795

Dorsalgia

323

893

1.92

23.54

1.4

14.16

14.67

pmol/l

0.78

267

773

Lower back pain or/and sciatica

363

1243

1.82

23.29

1.4

14.34

14.74

pmol/l

0.64

301

1053

Persons encountering health services for examination and investigation

185

385

2.42

23.28

1.4

14.97

14.92

pmol/l

0.02

153

334

Episodal and paroxysmal disorders

354

968

1.86

23.15

1.4

14.47

14.79

pmol/l

0.41

303

817

Obesity

235

1085

2.04

23.15

1.3

1.4

13.25

14.64

pmol/l

3.54

196

920

Non-selective monoamine reuptake inhibitors

133

492

2.60

23.12

1.5

14.52

16.10

pmol/l

2.19

102

425

Asthma (mode)

251

631

2.09

23.09

1.4

14.43

14.38

pmol/l

0.04

215

536

Dental caries

273

3.19

23.08

1.5

1.3

16.98

14.90

pmol/l

0.59

232

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

301

1063

1.91

23.07

1.3

1.5

16.24

14.34

pmol/l

1.86

245

899

Obesity and other hyperalimentation

235

1087

2.04

22.94

1.3

1.4

13.25

14.63

pmol/l

3.51

196

922

Fever of other and unknown origin

182

700

2.26

22.72

1.4

16.73

14.66

pmol/l

1.12

154

593

All-cause Heart Failure

171

503

2.37

22.70

1.4

1.5

16.89

15.26

pmol/l

1.80

140

413

Other disorders of adrenal gland

6.65

22.60

1.5

15.06

14.53

pmol/l

0.30

Hypertensive diseases (excluding secondary)

176

431

2.38

22.50

1.5

1.4

14.75

13.61

pmol/l

1.04

153

364

Other symptoms and signs involving cognitive functions and awareness

154

568

2.41

22.42

1.5

14.67

15.57

pmol/l

0.98

122

473

Persons encountering health services in other circumstances

158

665

2.36

22.41

1.4

14.26

14.91

pmol/l

0.83

128

556

Asthma (only as main-diagnosis), excluding more controls

226

585

2.14

22.30

1.4

1.5

14.63

14.19

pmol/l

0.38

193

497

Pain, not elsewhere classified

108

384

2.82

22.20

1.5

1.4

13.73

14.87

pmol/l

1.53

318

Hypertension, essential

239

650

2.08

22.15

1.5

1.4

14.70

14.21

pmol/l

0.38

210

540

Symptoms and signs involving the nervous and musculoskeletal systems

205

976

2.11

22.12

1.4

14.16

15.02

pmol/l

1.58

172

818

Sleep disorders

317

1181

1.85

22.08

1.4

14.07

14.93

pmol/l

2.10

267

998

Oedema, not elsewhere classified

114

408

2.74

22.01

1.4

1.5

13.67

15.30

pmol/l

2.88

333

Asthma

250

627

2.06

21.99

1.3

1.4

14.50

14.38

pmol/l

0.10

215

533

Type 2 diabetes, strict (exclude DM1)

308

953

1.88

21.78

1.4

14.66

14.79

pmol/l

0.10

262

795

Convulsions, not elsewhere classified

285

3.10

21.50

1.4

1.5

12.71

14.42

pmol/l

2.96

229

Osteopathies and chondropathies

201

874

2.11

21.41

1.5

15.32

15.00

pmol/l

0.34

167

725

Type 2 diabetes, definitions combined

306

953

1.87

21.23

1.4

14.66

14.78

pmol/l

0.09

260

795

Other intervertebral disc disorders

263

799

1.97

21.21

1.6

1.4

14.68

14.84

pmol/l

0.14

214

687

Use of hypnotics and sedatives

335

1054

1.82

21.20

1.4

14.27

14.92

pmol/l

1.25

276

897

Gastro-oesophageal reflux disease

229

964

2.01

21.11

1.5

1.4

14.97

14.72

pmol/l

0.27

189

812

Other dorsopathies, not elsewhere classified

320

897

1.86

21.05

1.4

14.38

14.68

pmol/l

0.37

261

776

Caries of dentine

243

3.23

20.84

1.5

1.3

17.44

14.80

pmol/l

0.70

210

Hypertensive diseases

242

676

2.02

20.82

1.5

1.4

15.06

14.22

pmol/l

0.62

209

563

Other symptoms and signs involving the nervous and musculoskeletal systems

153

664

2.31

20.81

1.4

13.82

15.16

pmol/l

2.37

130

545

Hypertension

242

676

2.02

20.81

1.5

1.4

15.06

14.22

pmol/l

0.62

209

563

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

319

1187

1.81

20.77

1.4

16.08

14.34

pmol/l

1.85

267

998

Schizophrenia or delusion

124

491

2.54

20.66

1.5

13.27

14.89

pmol/l

2.54

417

Dysphagia

323

2.92

20.61

1.3

1.4

15.25

15.54

pmol/l

0.20

265

Other heart diseases

152

411

2.41

20.61

1.4

16.40

13.64

pmol/l

1.83

127

346

Emergency coronary revascularization (for ACS)

258

799

1.95

20.50

1.5

1.4

16.84

14.82

pmol/l

1.83

221

664

Other heart diseases, wide

296

963

1.86

20.48

1.4

16.29

13.90

pmol/l

2.81

254

816

Disorders of calcium metabolism

6.10

20.30

1.9

1.4

14.86

15.89

pmol/l

0.54

Cardiovascular diseases

213

535

2.12

20.30

1.5

1.4

14.70

13.40

pmol/l

1.66

184

458

Schizophrenia, schizotypal and delusional disorders

124

496

2.51

20.24

1.5

13.27

14.89

pmol/l

2.56

421

Spondylopathies

236

698

2.00

20.03

1.3

1.4

15.29

14.90

pmol/l

0.43

188

600

Implicit bacterial Sepsis

134

472

2.44

19.98

1.3

1.4

16.84

15.15

pmol/l

0.66

111

391

Asthma (only as main-diagnosis)

228

627

2.04

19.95

1.4

14.66

14.38

pmol/l

0.22

195

533

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

296

952

1.85

19.88

1.5

1.4

14.62

14.82

pmol/l

0.24

249

792

Bacterial Sepsis

149

532

2.32

19.73

1.3

1.5

16.87

15.02

pmol/l

0.81

125

442

Implicit bacterial Sepsis, including avohilmo

145

516

2.34

19.65

1.2

1.5

16.68

15.11

pmol/l

0.67

121

428

Disorders of mineral metabolism

5.04

19.48

1.8

1.4

14.57

15.22

pmol/l

0.37

Chronic kidney disease

104

373

2.69

19.42

1.3

1.5

17.25

16.26

pmol/l

0.33

301

Pain in limb

269

911

1.88

19.37

1.5

1.4

15.06

14.61

pmol/l

0.27

225

779

Sleep apnoea, including avohilmo

319

1081

1.79

19.36

1.5

1.4

14.10

15.00

pmol/l

2.13

272

910

Lumbar disc prolapse

206

751

2.04

19.27

1.5

1.4

14.33

14.94

pmol/l

0.77

165

646

Percutaneous Coronary Intervention

238

739

1.96

19.24

1.5

16.75

14.71

pmol/l

1.67

204

619

First line medication for Crohn's disease

349

1075

1.75

19.19

1.4

15.72

14.27

pmol/l

1.61

300

902

Ischemic heart diseases

251

777

1.93

19.16

1.4

1.5

16.83

14.65

pmol/l

1.88

215

650

Coronary revascularization (ANGIO or CABG)

238

740

1.96

19.10

1.5

16.77

14.72

pmol/l

1.68

204

620

Diarrhoea and gastroenteritis of presumed infectious origin

238

1119

1.90

19.03

1.4

15.06

14.63

pmol/l

0.29

192

956

Major coronary heart disease event

250

780

1.92

18.95

1.5

1.4

16.84

14.73

pmol/l

1.75

213

653

Type 2 diabetes, definitions combined, including avohilmo

300

958

1.81

18.92

1.4

14.64

14.76

pmol/l

0.09

254

799

Hard cardiovascular diseases

251

778

1.91

18.66

1.5

1.4

16.83

14.52

pmol/l

2.10

218

658

Insomnia

304

1193

1.78

18.64

1.4

14.05

14.86

pmol/l

1.87

257

1007

Heart failure and coronary heart disease

119

328

2.55

18.51

1.4

1.5

20.09

15.64

pmol/l

1.77

100

260

Other (not insulin) diabetes medications

309

1019

1.78

18.51

1.5

1.4

14.38

14.95

pmol/l

0.89

255

855

Diseases of oesophagus, stomach and duodenum

336

1143

1.74

18.50

1.4

14.90

14.67

pmol/l

0.21

281

967

ILD medications: prednisolone, methylprednisolone, prednisone

341

1093

1.74

18.47

1.4

15.72

14.30

pmol/l

1.52

294

916

Paroxysmal tachycardia

212

3.11

18.44

1.5

1.4

18.30

13.73

pmol/l

1.64

177

Persons encountering health services for specific procedures and health care

345

1186

1.72

18.29

1.3

1.5

14.90

14.53

pmol/l

0.31

305

987

Type 2 diabetes, wide definition

238

784

1.92

18.20

1.5

1.4

14.92

15.05

pmol/l

0.13

198

653

Constipation

280

1050

1.81

18.19

1.5

1.4

14.76

14.77

pmol/l

0.01

237

878

Dorsopathies

316

901

1.78

18.15

1.4

14.18

14.68

pmol/l

0.74

260

780

Valvular heart disease excluding rheumatic fever

137

417

2.35

18.11

1.4

1.5

15.60

14.47

pmol/l

1.88

114

344

Hypotension

194

3.37

18.11

1.4

18.60

15.97

pmol/l

0.63

155

Oral corticosteroids

336

1142

1.73

18.09

1.5

1.4

15.83

14.31

pmol/l

1.68

292

952

Tramadol

248

792

1.89

17.87

1.4

1.5

14.18

14.82

pmol/l

0.93

201

673

Pain in joint

177

513

2.12

17.76

1.5

1.4

13.76

14.79

pmol/l

1.72

143

441

Dizziness and giddiness

234

968

1.88

17.74

1.4

15.07

14.82

pmol/l

0.16

189

818

Vocal cord dysfunction

4.28

17.72

1.6

1.4

14.06

13.97

pmol/l

0.05

Symptoms and signs concerning food and fluid intake

131

3.91

17.68

1.7

1.5

15.98

14.61

pmol/l

1.11

105

Iron deficiency anaemia

148

666

2.19

17.64

1.3

1.4

16.57

15.29

pmol/l

0.52

115

558

Nausea and vomiting

102

387

2.58

17.60

1.4

14.78

15.12

pmol/l

0.23

327

Non-rheumatic valve diseases

135

415

2.33

17.45

1.4

1.5

15.59

14.47

pmol/l

1.84

112

343

Disorders of adult personality and behaviour

115

477

2.42

17.44

1.5

12.60

14.40

pmol/l

3.05

401

Epilepsy

100

387

2.58

17.42

1.5

1.4

13.36

15.46

pmol/l

2.40

311

Substance abuse

174

793

2.04

17.25

1.3

1.4

14.01

14.92

pmol/l

1.17

135

680

Parasetamol

217

556

1.98

17.14

1.5

1.4

14.77

14.40

pmol/l

0.23

189

472

Other and unspecified nonorganic psychotic disorders

303

2.79

16.94

1.5

1.6

13.21

14.54

pmol/l

1.48

261

Sleep apnoea

291

1046

1.76

16.91

1.5

1.4

14.27

15.03

pmol/l

1.51

249

878

Implicit viral Sepsis, including avohilmo

106

429

2.47

16.87

1.2

1.5

17.11

14.91

pmol/l

0.81

352

Implicit viral Sepsis

272

2.88

16.75

1.3

1.4

17.78

14.69

pmol/l

0.89

220

Viral Sepsis

272

2.88

16.75

1.3

1.4

17.78

14.69

pmol/l

0.89

220

Non-ischemic cardiomyopathy

288

2.65

16.74

1.4

1.5

16.56

15.83

pmol/l

0.46

235

Generalized anxiety disorder

261

2.92

16.73

1.4

1.5

13.38

14.49

pmol/l

0.97

223

Myalgia

369

2.59

16.58

1.2

1.4

13.81

14.64

pmol/l

0.72

310

Asthma, unspecified (mode), excluding more controls

161

549

2.10

16.38

1.5

14.88

14.27

pmol/l

0.41

139

463

GASTRO-related operations

249

675

1.85

16.33

1.4

15.00

13.98

pmol/l

1.37

220

569

Any gastric operation

249

675

1.85

16.33

1.4

15.00

13.98

pmol/l

1.37

220

569

Codeine

290

896

1.75

16.16

1.4

14.50

14.57

pmol/l

0.07

248

767

Poisoning by drugs, medicaments and biological substances

392

2.51

16.12

1.3

1.5

12.79

14.41

pmol/l

2.07

333

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

104

196

2.67

16.08

1.5

1.4

15.18

14.22

pmol/l

0.41

172

Personality disorders

108

453

2.39

16.03

1.4

1.5

12.56

14.46

pmol/l

2.93

385

Spinal stenosis

144

493

2.16

15.75

1.3

1.5

15.25

15.47

pmol/l

0.16

112

427

Concussion

152

562

2.10

15.73

1.4

14.41

14.51

pmol/l

0.07

118

482

280

939

1.75

15.72

1.3

1.4

15.48

14.41

pmol/l

0.92

238

793

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

280

939

1.75

15.72

1.3

1.4

15.48

14.41

pmol/l

0.92

238

793

Nutritional anaemias

161

760

2.02

15.69

1.3

1.4

16.40

15.31

pmol/l

0.47

125

639

Hyperparathyroidism

241

2.93

15.68

1.5

16.25

15.66

pmol/l

0.26

194

All chronic kidney diseases

165

650

2.03

15.64

1.4

16.30

15.25

pmol/l

0.63

144

534

ILD medications

343

1119

1.65

15.57

1.5

1.4

15.82

14.30

pmol/l

1.72

298

940

Mental and behavioural disorders due to psychoactive substance use

175

819

1.96

15.50

1.3

1.4

14.02

14.89

pmol/l

1.12

136

704

Intestinal infectious diseases

298

1318

1.68

15.44

1.4

14.98

14.63

pmol/l

0.27

246

1119

Other diseases of intestines

326

1090

1.67

15.40

1.4

14.18

14.65

pmol/l

0.77

276

927

Atrial fibrillation and flutter

209

2.72

15.32

1.8

1.4

17.88

13.94

pmol/l

2.64

181

Diabetes, insulin treatment (Kela reimbursement)

303

1069

1.69

15.22

1.5

1.4

14.56

14.97

pmol/l

0.57

254

893

Diseases of arteries, arterioles and capillaries (FINNGEN)

151

3.12

15.21

1.5

16.38

14.09

pmol/l

0.60

132

Intracranial trauma

170

573

2.01

15.15

1.3

1.4

14.23

14.48

pmol/l

0.20

130

492

Renal failure

137

547

2.14

15.13

1.3

1.4

16.64

15.89

pmol/l

0.33

121

446

Migraine with aura

410

2.42

15.12

1.5

1.4

13.40

13.92

pmol/l

0.49

345

Hyperkinetic disorders, excluding more controls

149

3.40

15.06

1.4

1.3

13.14

14.37

pmol/l

0.81

132

Visual disturbances

164

833

1.97

15.05

1.5

1.4

14.36

15.12

pmol/l

1.12

139

695

Disorders of lipoprotein metabolism and other lipidaemias

216

709

1.85

14.95

1.5

1.4

14.03

14.71

pmol/l

0.87

183

592

Oxycodone

123

475

2.22

14.92

1.4

1.5

15.91

15.28

pmol/l

0.22

399

Poisoning by medicine

366

2.50

14.84

1.2

1.5

12.97

14.37

pmol/l

1.51

311

Emotionally unstable personality disorder

199

3.09

14.79

1.4

11.86

14.50

pmol/l

3.12

167

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

315

1225

1.65

14.78

1.4

14.97

14.68

pmol/l

0.25

259

1042

Other/unspecified dorsalgia

120

539

2.20

14.73

1.5

1.4

14.32

15.02

pmol/l

0.66

103

462

Visual disturbances and blindness

171

888

1.93

14.67

1.5

1.4

14.45

15.10

pmol/l

0.93

144

738

Nonorganic sleeping disorders

369

2.48

14.59

1.5

14.04

14.54

pmol/l

0.41

317

Other CVD

238

2.87

14.55

1.5

18.38

15.88

pmol/l

0.64

191

Inflammatory bowel disease treatment related agents

345

1184

1.62

14.51

1.5

1.4

15.82

14.30

pmol/l

1.76

301

990

Diseases of salivary glands

120

550

2.19

14.51

1.5

1.4

14.10

15.16

pmol/l

1.20

100

456

Asthma, unspecified (mode)

163

591

1.99

14.50

1.5

14.93

14.46

pmol/l

0.30

141

499

Care involving use of rehabilitation procedures

199

975

1.84

14.49

1.3

1.5

13.68

14.69

pmol/l

2.63

176

801

Specific personality disorders

407

2.39

14.44

1.5

12.31

14.20

pmol/l

3.51

347

Weight loss

123

3.69

14.41

1.6

15.85

14.60

pmol/l

0.88

102

Cerebrovascular diseases (FINNGEN)

252

2.54

14.18

1.5

1.4

14.82

13.88

pmol/l

0.98

213

STROKE

156

521

2.02

14.16

1.4

15.49

14.45

pmol/l

0.69

134

435

Soft tissue disorders

305

939

1.67

14.11

1.4

14.65

14.64

pmol/l

0.01

248

805

Sciatica+with lumbago

158

714

1.96

14.02

1.4

14.56

14.81

pmol/l

0.23

138

611

Syncope and collapse

126

492

2.14

13.98

1.3

1.5

16.31

14.97

pmol/l

0.45

100

408

Phobic anxiety disorders

195

3.03

13.94

1.4

1.5

13.54

14.65

pmol/l

0.87

165

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

110

497

2.22

13.81

1.3

1.5

12.51

14.34

pmol/l

3.00

419

Glucagon-like peptide-1 (GLP-1) analogues

101

443

2.29

13.61

1.3

1.4

13.73

15.30

pmol/l

1.72

381

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

101

443

2.29

13.61

1.3

1.4

13.73

15.30

pmol/l

1.72

381

Other and unspecified iron deficiency

117

544

2.15

13.60

1.4

17.01

15.25

pmol/l

0.60

451

Opioids

292

907

1.66

13.53

1.4

14.47

14.58

pmol/l

0.07

246

776

Abnormal weight loss

115

3.68

13.43

1.6

1.5

16.01

14.61

pmol/l

1.07

Other disorders of skin and subcutaneous tissue

221

1071

1.74

13.41

1.6

1.4

15.22

14.80

pmol/l

0.52

187

890

Polycystic ovarian syndrome, consortium definition

269

917

1.69

13.39

1.4

13.80

14.45

pmol/l

1.46

226

769

Abdominal and pelvic pain

276

825

1.68

13.22

1.4

15.38

14.69

pmol/l

0.58

235

705

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

295

1147

1.63

13.11

1.4

16.13

14.12

pmol/l

2.16

250

972

Obesity related asthma

113

528

2.15

13.07

1.5

1.4

14.06

15.19

pmol/l

1.54

439

Atrial fibrillation and flutter with reimbursement

153

2.85

13.00

1.7

1.6

18.73

14.17

pmol/l

2.32

131

Osteoporosis with pathological fracture (FG)

3.99

12.89

1.5

1.7

17.19

16.26

pmol/l

0.36

Missing teeth due to accident, extraction or parodontitis

184

908

1.81

12.86

1.5

1.4

15.17

pmol/l

0.00

143

761

Acute upper respiratory infections of multiple and unspecified sites

240

1035

1.69

12.80

1.4

14.85

14.71

pmol/l

0.09

196

877

Asthma (diagnoses ohter than nonallergic)

268

1325

1.64

12.74

1.4

14.69

14.56

pmol/l

0.10

231

1112

Rheumatism, unspecified

190

2.96

12.74

1.3

1.5

13.86

15.45

pmol/l

1.36

157

Cervical disc disorders

105

482

2.18

12.71

1.7

1.5

14.41

15.26

pmol/l

0.82

418

Type 1 diabetes

338

2.43

12.70

1.5

15.05

14.82

pmol/l

0.14

283

Hypertensive heart and/or renal disease

168

2.83

12.67

1.4

16.35

15.87

pmol/l

0.19

133

Codeine or tramadol medication

336

1162

1.57

12.59

1.4

14.56

14.72

pmol/l

0.19

284

990

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

157

805

1.88

12.57

1.4

13.84

14.87

pmol/l

1.79

130

676

Chronic lower respiratory diseases

357

1213

1.55

12.55

1.4

14.81

14.56

pmol/l

0.24

309

1018

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

4.17

12.51

1.6

1.7

14.47

15.14

pmol/l

0.35

Hypertensive Heart Disease

152

2.95

12.49

1.4

1.5

16.66

15.82

pmol/l

0.35

122

Other and unspecified mood [affective] disorders

3.81

12.43

1.5

12.59

15.39

pmol/l

1.56

Infections, IBD-co-morbidities

3.86

12.37

1.2

16.54

13.56

pmol/l

0.59

KRA_PSY_EATING, excluding more controls

102

3.71

12.32

1.2

1.4

12.34

13.55

pmol/l

0.83

Erysipelas

154

702

1.89

12.31

1.4

15.38

15.19

pmol/l

0.12

132

576

Alzheimer’s disease (Atypical or mixed), excluding more controls

5.12

12.30

1.4

1.6

18.00

16.53

pmol/l

0.39

Follow-up examination after treatment for conditions other than malignant neoplasms

113

349

2.16

12.25

1.3

1.4

14.30

14.86

pmol/l

0.40

300

Other pulmonary diagnosis

221

635

1.75

12.13

1.5

1.4

15.56

14.36

pmol/l

0.86

188

538

Schizoaffective disorder

114

3.54

12.10

1.2

1.5

12.77

15.27

pmol/l

1.51

Symptoms and signs involving the digestive system and abdomen

271

825

1.65

12.08

1.4

15.24

14.69

pmol/l

0.46

230

705

Pure hypercholesterolaemia

186

658

1.80

11.89

1.5

1.4

14.01

14.82

pmol/l

0.97

159

547

Renal tubulo-interstitial diseases

258

1165

1.62

11.79

1.4

15.82

14.42

pmol/l

1.76

221

975

Complications of surgical and medical care, not elsewhere classified

292

1233

1.58

11.75

1.4

14.50

14.71

pmol/l

0.25

240

1041

Disorders of eyelid, lacrimal system and orbit

259

1174

1.62

11.66

1.4

14.47

14.72

pmol/l

0.35

216

982

Other bacterial diseases

269

1108

1.61

11.63

1.4

15.24

14.87

pmol/l

0.24

226

926

Other bacterial diseases, including avohilmo

296

1173

1.58

11.61

1.4

15.16

14.62

pmol/l

0.44

251

986

Pacemaker

402

2.20

11.61

1.3

1.5

20.33

15.79

pmol/l

1.54

317

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

344

2.26

11.47

1.4

1.5

12.88

13.80

pmol/l

1.10

301

Excluding asthma or asthma-COPD overlap

218

635

1.72

11.45

1.5

1.4

15.55

14.36

pmol/l

0.85

187

538

Covid-19 confirmed case

116

576

2.02

11.44

1.3

1.4

14.19

15.56

pmol/l

1.69

467

Irregular menses

181

769

1.77

11.43

1.3

1.4

13.28

14.04

pmol/l

1.66

158

647

Ischaemic heart disease, wide definition

204

728

1.73

11.35

1.4

1.5

15.82

15.07

pmol/l

0.52

171

611

Post-traumatic stress disorder

134

3.23

11.34

1.4

13.68

14.73

pmol/l

0.47

116

329

1081

1.54

11.30

1.5

1.4

14.84

14.76

pmol/l

0.07

277

912

Influenza and pneumonia

317

1269

1.54

11.30

1.4

15.95

14.27

pmol/l

1.74

269

1073

Statin medication

203

659

1.74

11.29

1.5

14.53

14.57

pmol/l

0.02

173

557

Intestinal infectious diseases, including avohilmo, including avohilmo

333

1212

1.53

11.25

1.4

1.5

15.14

14.64

pmol/l

0.49

274

1030

Alcohol use disorder, ICD-based

111

547

2.03

11.23

1.2

1.4

14.59

14.90

pmol/l

0.20

461

Mental and behavioural disorders due to alcohol, excluding acute intoxication

118

589

1.99

11.21

1.2

1.5

14.51

14.87

pmol/l

0.25

496

Spondylosis

146

610

1.87

11.14

1.4

15.24

15.14

pmol/l

0.07

108

524

Heart failure and bmi 25plus

281

2.24

11.11

1.5

1.4

20.13

14.95

pmol/l

2.01

222

Mental and behavioural disorders due to alcohol

135

680

1.89

11.04

1.2

1.4

14.44

14.90

pmol/l

0.37

104

586

Insulin, fast-acting

107

524

2.05

11.00

1.5

14.82

15.30

pmol/l

0.37

434

Bleeding

228

971

1.65

10.99

1.4

1.5

15.65

14.92

pmol/l

0.54

184

819

Biguanides

272

1035

1.59

10.97

1.5

1.4

14.49

14.99

pmol/l

0.68

223

870

Other specific joint derangements/joint disorders

223

836

1.66

10.90

1.4

13.52

14.50

pmol/l

1.99

187

704

Suicide or other Intentional self-harm

389

2.22

10.88

1.3

1.5

12.45

14.80

pmol/l

3.52

330

Intracranial injury

172

918

1.75

10.82

1.2

1.4

14.57

14.89

pmol/l

0.28

129

782

Type 1 diabetes, wide definition, subgroup 1

290

2.42

10.81

1.6

1.5

15.17

14.83

pmol/l

0.19

243

COPD differential diagnosis

214

631

1.70

10.80

1.5

1.4

15.60

14.38

pmol/l

0.86

183

536

ILD differential diagnosis

214

631

1.70

10.80

1.5

1.4

15.60

14.38

pmol/l

0.86

183

536

Complications of medical and surgical care

218

1195

1.64

10.79

1.4

14.63

14.69

pmol/l

0.06

183

995

Other disorders of urethra and urinary system

213

892

1.66

10.64

1.7

1.4

14.92

14.61

pmol/l

0.27

175

762

Insulin, fast-acting or short human

107

531

2.02

10.63

1.5

14.82

15.28

pmol/l

0.36

441

Pain (limb, back, neck, head abdominally)

184

522

1.77

10.62

1.5

1.4

15.26

14.83

pmol/l

0.23

156

450

All kidney diseases

288

1248

1.55

10.61

1.4

15.39

14.43

pmol/l

1.11

241

1048

Erysipelas, including avohilmo

205

910

1.67

10.55

1.4

1.5

15.24

14.98

pmol/l

0.21

173

759

Pneumonias (Asthma/COPD co-morbidities)

298

1270

1.53

10.51

1.4

16.12

14.27

pmol/l

1.85

254

1072

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

169

973

1.74

10.48

1.4

14.53

15.02

pmol/l

0.55

141

817

Complications of procedures, not elsewhere classified

235

1181

1.60

10.46

1.4

14.13

14.70

pmol/l

0.91

196

993

Obsessive-compulsive disorder

3.57

10.45

1.4

13.15

14.95

pmol/l

0.75

Diseases of the digestive system

128

675

1.89

10.43

1.5

1.4

15.77

15.28

pmol/l

0.17

101

561

Hypokalaemia

131

3.14

10.40

1.2

1.4

14.78

15.76

pmol/l

0.56

108

Mouth breathing

107

535

2.00

10.39

1.6

1.5

14.04

15.14

pmol/l

1.48

451

Alcohol use disorder, Swedish definition

141

701

1.83

10.33

1.2

1.4

14.66

15.08

pmol/l

0.33

109

596

COPD/asthma related infections

291

939

1.55

10.30

1.5

1.4

15.49

14.41

pmol/l

1.01

249

793

COPD/asthma/ILD related infections

291

939

1.55

10.30

1.5

1.4

15.49

14.41

pmol/l

1.01

249

793

Asthma, hospital admission 2, infections

177

1013

1.71

10.30

1.4

1.5

14.95

14.80

pmol/l

0.09

148

847

Asthma-related infections

177

1013

1.71

10.30

1.4

1.5

14.95

14.80

pmol/l

0.09

148

847

Use of biperiden

4.43

10.27

1.3

1.6

12.82

16.66

pmol/l

1.18

Chronic diseases of tonsils and adenoids

236

924

1.61

10.26

1.4

14.60

14.64

pmol/l

0.04

198

790

Amenorrhoea

107

3.39

10.26

1.4

1.2

12.70

13.36

pmol/l

0.45

Acute upper respiratory infections

300

1180

1.52

10.16

1.5

1.4

14.75

14.79

pmol/l

0.02

255

996

245

2.50

10.13

1.3

1.5

12.91

14.24

pmol/l

1.76

205

Iron deficiency anaemia secondary to blood loss (chronic)

216

2.60

10.10

1.4

1.5

16.92

15.26

pmol/l

0.31

178

All pneumoniae

298

1277

1.52

10.02

1.4

16.13

14.29

pmol/l

1.83

254

1079

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

283

2.38

9.98

1.3

1.5

12.04

14.61

pmol/l

3.81

240

Focal epilepsy

296

2.34

9.91

1.4

1.5

13.30

15.45

pmol/l

1.75

246

Haemorrhage from respiratory passages

355

2.15

9.88

1.6

1.5

15.07

pmol/l

0.00

297

Allergic asthma (mode), excluding more controls

320

2.26

9.82

1.4

13.56

13.79

pmol/l

0.20

266

Bronchitis

316

1269

1.49

9.77

1.4

14.82

14.63

pmol/l

0.15

258

1078

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

178

1042

1.68

9.76

1.4

14.51

14.85

pmol/l

0.35

150

868

Substance use, excluding alcohol

286

2.35

9.75

1.5

13.03

15.08

pmol/l

2.00

243

ILD medications: immunosuppressive drugs

186

1015

1.66

9.73

1.4

15.09

14.29

pmol/l

0.69

162

846

Somatoform disorder

244

2.47

9.72

1.5

13.43

14.96

pmol/l

1.36

209

Type 1 diabetes, wide definition

305

2.30

9.70

1.6

1.5

15.17

14.78

pmol/l

0.22

255

Panic disorder

221

2.54

9.66

1.5

13.86

14.52

pmol/l

0.36

191

Falls/tendency to fall

307

1018

1.51

9.66

1.4

1.5

14.99

14.35

pmol/l

0.58

245

892

Irritable bowel syndrome

449

2.06

9.64

1.4

13.66

15.10

pmol/l

1.70

374

Allergic asthma (mode)

323

2.24

9.62

1.4

13.56

13.90

pmol/l

0.33

270

Postmenopausal osteoporosis with pathological fracture

3.51

9.62

1.6

17.25

16.07

pmol/l

0.62

Insulin medication

156

747

1.73

9.45

1.5

1.4

14.73

15.25

pmol/l

0.58

135

617

Obesity, other/unspecified

108

562

1.93

9.45

1.4

1.5

13.41

14.62

pmol/l

1.27

475

Triptan medication for migraine, min. 3 purchases

194

884

1.64

9.42

1.4

1.5

13.50

14.08

pmol/l

1.02

165

761

Vitamin deficiency, wide

4.38

9.33

1.5

14.67

14.52

pmol/l

0.05

Vitamin deficiency

4.38

9.33

1.5

14.67

14.52

pmol/l

0.05

Focal epilepsy, strict definition

267

2.37

9.33

1.4

1.5

13.26

15.45

pmol/l

1.84

224

Disorder of lipoprotein metabolism, unspecified

119

3.12

9.31

1.2

1.3

15.25

16.49

pmol/l

0.65

Extrapyramidal and movement disorders

110

579

1.90

9.30

1.4

14.03

15.86

pmol/l

3.16

477

154

776

1.73

9.28

1.2

1.4

14.53

14.99

pmol/l

0.41

120

659

Nerve, nerve root and plexus disorders

298

1198

1.50

9.26

1.5

1.4

13.80

14.98

pmol/l

3.47

250

1010

Organic, including symptomatic, mental disorders

127

485

1.84

9.15

1.3

1.5

15.65

16.31

pmol/l

0.55

404

Other disorders of skin and subcutaneous tissue, not elsewhere classified

192

2.62

9.13

1.6

1.4

15.51

15.15

pmol/l

0.14

160

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

285

1269

1.50

9.08

1.4

16.20

14.34

pmol/l

1.73

241

1073

Hyperhidrosis

4.62

9.07

1.6

1.5

12.57

14.12

pmol/l

0.68

Deforming dorsopathies

406

2.07

9.04

1.5

14.76

15.45

pmol/l

0.49

349

Persons encountering health services in other circumstances, wide

317

1104

1.48

9.01

1.4

14.59

14.82

pmol/l

0.20

268

930

145

746

1.74

8.97

1.2

1.4

14.58

14.98

pmol/l

0.32

112

635

Asthma, hospital admissions , main diagnosis only

238

1349

1.54

8.96

1.4

14.69

14.60

pmol/l

0.06

203

1137

Cough

113

565

1.87

8.96

1.4

15.90

14.58

pmol/l

0.75

475

Mental disorders, not otherwise specified

133

2.95

8.91

1.3

1.6

13.96

14.91

pmol/l

0.42

107

Insulin, intermediate and long-acting

140

775

1.75

8.90

1.4

14.70

15.18

pmol/l

0.50

120

638

Dipeptidyl peptidase 4 (DPP-4) inhibitors

140

624

1.76

8.88

1.6

1.4

14.63

15.72

pmol/l

1.61

120

521

Other disorders of lacrimal gland

120

661

1.82

8.83

1.5

15.14

15.31

pmol/l

0.14

546

Other neurological diseases

193

929

1.61

8.81

1.4

15.00

15.14

pmol/l

0.08

160

772

Autoimmune diseases excluding thyroid diseases

210

709

1.61

8.80

1.4

14.94

14.39

pmol/l

0.46

190

611

Other joint disorders

253

858

1.54

8.77

1.4

13.80

14.54

pmol/l

1.35

216

724

134

759

1.75

8.73

1.4

14.88

14.92

pmol/l

0.02

107

630

Pneumonia, organism unspecified

260

1182

1.51

8.71

1.3

1.5

16.46

14.36

pmol/l

1.84

222

991

Menorrhagia

120

357

1.88

8.70

1.5

1.4

14.06

14.73

pmol/l

0.76

295

Migraine with aura and triptan purchases

295

2.25

8.69

1.5

1.4

13.04

14.26

pmol/l

1.22

246

Insulin, combination of fast acting with intermediate-acting or long-acting

156

842

1.68

8.62

1.5

1.4

14.73

15.18

pmol/l

0.50

135

690

Hernia of abdominal wall, postoperative

208

2.49

8.62

1.5

14.46

14.60

pmol/l

0.06

170

Asthma, including avohilmo

332

1266

1.44

8.59

1.4

14.69

14.66

pmol/l

0.03

286

1066

Delirium, not induced by alcohol and other psychoactive substances

125

2.96

8.55

1.2

1.5

15.25

15.76

pmol/l

0.26

100

Bacterial infection, other or unspecified, including avohilmo

153

741

1.69

8.54

1.4

15.58

15.02

pmol/l

0.24

129

607

Fracture of femur

318

2.13

8.53

1.6

1.4

14.68

16.80

pmol/l

2.09

252

Mental and behavioural disorders due to sedatives or hypnotics

3.36

8.48

1.2

1.5

13.06

15.45

pmol/l

1.08

Decubitus ulcer and pressure area

4.18

8.45

1.4

1.6

17.73

15.13

pmol/l

0.86

Benign neoplasms

266

962

1.51

8.44

1.5

1.4

15.06

14.25

pmol/l

0.78

227

806

Asthma/COPD (KELA code 203)

270

1213

1.49

8.44

1.4

14.57

14.56

pmol/l

0.01

232

1018

Gastrointestinal diseases

168

499

1.69

8.40

1.4

14.73

14.10

pmol/l

0.43

141

423

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

4.08

8.36

1.6

1.2

15.79

13.56

pmol/l

0.93

Other degenerative diseases of the nervous system

227

2.22

8.33

1.3

1.5

16.01

pmol/l

0.00

186

Abnormal findings on examination of blood, without diagnosis

115

574

1.82

8.31

1.3

1.4

14.37

15.41

pmol/l

1.08

471

Aplastic and other anaemias

122

629

1.78

8.23

1.5

1.4

15.10

15.92

pmol/l

0.76

106

517

Hyperlipidaemia, other/unspecified

394

1.96

7.91

1.6

1.4

14.59

15.57

pmol/l

1.01

325

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

113

389

1.83

7.88

1.6

1.4

13.42

13.57

pmol/l

0.13

327

Bacterial infection, other or unspecified

137

680

1.70

7.86

1.4

1.5

15.50

15.22

pmol/l

0.10

114

558

Dental pulpitis, including avohilmo

263

1143

1.47

7.83

1.3

1.4

13.62

14.71

pmol/l

2.84

223

974

Mycoses

444

1.94

7.79

1.6

1.5

14.57

15.42

pmol/l

0.74

367

Provisional assignment of new diseases of uncertain etiology

152

920

1.64

7.78

1.5

1.4

14.14

14.88

pmol/l

1.01

126

763

Primary hyperparathyroidism

161

2.62

7.76

1.7

1.6

15.30

15.31

pmol/l

0.00

135

Codes for special purposes

152

921

1.64

7.75

1.5

1.4

14.14

14.88

pmol/l

1.01

126

764

Sub-endpoint used in defining T1D endpoints

417

1.96

7.73

1.5

15.03

15.06

pmol/l

0.02

349

Polyarthropathies

180

724

1.60

7.73

1.4

15.52

14.68

pmol/l

0.57

158

605

Symptoms and signs involving speech and voice

537

1.85

7.72

1.4

15.86

15.12

pmol/l

0.30

439

Insulin, fast-acting (human)

209

2.40

7.72

1.6

1.5

14.14

14.59

pmol/l

0.25

175

Other symptoms and signs involving the digestive system and abdomen

247

2.28

7.66

1.7

1.4

14.56

15.01

pmol/l

0.26

205

Symptoms and signs involving the skin and subcutaneous tissue

205

1272

1.52

7.61

1.5

1.4

14.67

14.66

pmol/l

0.01

180

1056

Migraine without aura

332

2.08

7.60

1.5

1.4

13.44

13.70

pmol/l

0.18

274

Cellulitis

333

2.08

7.55

1.3

1.5

13.83

15.03

pmol/l

1.06

275

Coronary atherosclerosis

149

564

1.67

7.54

1.3

1.5

15.05

14.99

pmol/l

0.04

128

465

Focal epilepsy, mode (most common among epilepsy diagnosis)

255

2.24

7.54

1.5

13.22

15.38

pmol/l

1.66

216

Radiculopathy

194

2.43

7.46

1.3

1.5

13.54

16.43

pmol/l

1.92

165

Certain infectious and parasitic diseases

267

911

1.47

7.46

1.4

1.5

15.50

14.36

pmol/l

0.95

230

768

Benign neoplasm: Colon

139

786

1.66

7.45

1.5

15.83

15.59

pmol/l

0.10

124

643

Enthesopathies of lower limb, excluding foot

315

2.10

7.44

1.3

1.4

14.15

15.27

pmol/l

0.92

271

Other extrapyramidal and movement disorders in other diseases

383

1.99

7.40

1.4

1.5

14.46

16.00

pmol/l

1.53

316

Disorders of gallbladder, biliary tract and pancreas

263

1123

1.46

7.39

1.4

14.82

14.66

pmol/l

0.15

218

943

Dermatitis and eczema

309

1294

1.41

7.32

1.4

14.00

14.86

pmol/l

2.21

248

1106

Injuries to the head

310

1303

1.41

7.28

1.3

1.4

14.59

14.66

pmol/l

0.05

244

1121

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.11

7.28

1.4

1.5

14.73

15.16

pmol/l

0.10

Disorders of lacrimal system

135

801

1.66

7.28

1.5

1.4

14.80

15.24

pmol/l

0.49

110

664

Nail disorders

110

2.93

7.26

1.5

1.3

15.89

15.48

pmol/l

0.11

Use of disulfiram, acamprosate or naltrexone

110

2.93

7.26

1.3

1.7

13.12

15.14

pmol/l

1.06

Acute pharyngitis

219

2.31

7.25

1.1

1.4

13.17

14.10

pmol/l

0.88

185

Explicit Sepsis

110

570

1.76

7.24

1.3

1.4

15.51

14.87

pmol/l

0.35

477

Chronic periodontitis, including avohilmo

268

1184

1.45

7.23

1.5

1.4

15.17

14.75

pmol/l

0.33

222

997

Drug-induced adrenocortical insufficiency

7.41

7.22

1.8

1.9

14.06

15.96

pmol/l

0.71

External causes of morbidity and mortality

183

580

1.58

7.20

1.4

1.5

15.01

14.37

pmol/l

0.46

151

509

Chronic apical periodontitis

307

1218

1.41

7.19

1.4

15.47

14.37

pmol/l

1.05

249

1038

Cardiodefibrillation

407

1.94

7.17

1.7

1.4

17.43

16.13

pmol/l

0.47

327

Other gastritis (incl. Duodenitis)

300

2.11

7.16

1.4

15.44

15.70

pmol/l

0.11

250

Benign neoplasm of colon, rectum, anus and anal canal

161

857

1.59

7.14

1.5

1.4

15.69

15.47

pmol/l

0.11

143

702

Diseases of the respiratory system

166

515

1.62

7.12

1.6

1.5

15.22

14.35

pmol/l

0.64

141

432

Other diseases of urinary system

261

1010

1.45

7.05

1.5

1.4

14.65

14.48

pmol/l

0.16

209

866

Diverticular disease of intestine

174

688

1.58

7.05

1.4

15.35

15.31

pmol/l

0.03

143

578

Infections of the skin and subcutaneous tissue

158

983

1.58

7.05

1.3

1.4

14.22

14.84

pmol/l

0.32

137

825

Disturbance of activity and attention

238

2.22

6.99

1.4

1.5

13.14

13.87

pmol/l

0.54

204

Major coronary heart disease event excluding revascularizations

129

504

1.69

6.97

1.3

1.5

16.68

15.19

pmol/l

0.70

104

417

Alzheimer disease, excluding more controls

2.79

6.95

1.4

1.7

17.09

16.56

pmol/l

0.18

Other problems related to primary support group, including family circumstances

183

2.40

6.94

1.5

12.86

14.18

pmol/l

0.86

158

Other and unspecified anaemias

109

589

1.74

6.94

1.5

1.4

15.40

16.00

pmol/l

0.47

484

Cystitis

231

930

1.48

6.94

1.5

1.4

14.16

14.57

pmol/l

0.59

192

795

Diseases of arteries, arterioles and capillaries

156

717

1.60

6.90

1.6

1.4

16.13

15.37

pmol/l

0.38

130

589

Periodontitis

267

1189

1.43

6.89

1.6

1.4

15.19

14.74

pmol/l

0.35

221

1000

Seborrhoeic dermatitis

125

2.73

6.85

1.5

1.4

12.60

16.48

pmol/l

2.12

105

Disorders of ocular muscles, binocular movement, accommodation and refraction

141

867

1.61

6.84

1.5

1.4

14.39

14.64

pmol/l

0.27

120

731

Symptoms and signs involving the urinary system

196

979

1.51

6.83

1.4

14.53

15.18

pmol/l

0.95

153

816

Gastroduodenal ulcer

298

2.08

6.83

1.5

1.4

16.87

16.07

pmol/l

0.20

248

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

509

1.81

6.83

1.4

13.31

13.81

pmol/l

0.52

433

Parkinson's disease, excluding more controls

3.07

6.82

1.3

1.5

13.13

15.99

pmol/l

2.32

Diseases of the musculoskeletal system and connective tissue

146

444

1.65

6.81

1.4

14.00

14.32

pmol/l

0.31

123

383

Explicit Sepsis, including avohilmo

110

578

1.73

6.81

1.3

1.4

15.51

14.84

pmol/l

0.37

485

Other obstetric conditions, not elsewhere classified

116

423

1.73

6.80

1.4

13.44

12.89

pmol/l

0.72

100

366

Other specified and unspecified personality disorders

137

2.64

6.79

1.3

1.5

12.64

15.18

pmol/l

1.60

113

Traumatic subdural haemorrhage

2.93

6.77

1.2

1.5

14.26

16.66

pmol/l

0.91

Disturbances of skin sensation

460

1.85

6.74

1.5

1.4

13.61

14.76

pmol/l

1.15

380

Injuries to the abdomen, lower back, lumbar spine and pelvis

112

648

1.71

6.72

1.3

1.5

14.21

15.38

pmol/l

1.47

538

Persistent mood disorders

268

2.13

6.72

1.5

1.6

12.85

15.49

pmol/l

3.47

227

Disorders of synovium and tendon

146

774

1.60

6.71

1.4

13.88

14.71

pmol/l

1.45

126

659

Systemic connective tissue disorders

104

599

1.74

6.71

1.4

15.66

15.50

pmol/l

0.09

492

GI-bleeding

418

1.89

6.71

1.4

16.91

15.70

pmol/l

0.27

345

Fall on same level

312

1194

1.39

6.70

1.4

14.96

14.45

pmol/l

0.44

254

1038

Other anaemias

109

594

1.72

6.68

1.5

1.4

15.40

16.00

pmol/l

0.48

489

Diseases of pulp and periapical tissues, including avohilmo

275

1000

1.42

6.61

1.4

15.10

14.66

pmol/l

0.27

221

845

Disorders of skin appendages

145

909

1.59

6.61

1.5

1.4

14.80

14.56

pmol/l

0.10

120

775

Paralytic ileus and intestinal obstruction

330

2.00

6.60

1.3

1.4

15.27

16.33

pmol/l

0.75

275

Other systemic involvement of connective tissue (FG)

399

1.90

6.58

1.3

1.5

15.77

15.51

pmol/l

0.12

324

Secondary hypertension

3.17

6.51

1.2

1.5

15.21

13.62

pmol/l

0.89

Schizophrenia

233

2.20

6.48

1.4

1.5

12.63

15.47

pmol/l

2.66

199

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

113

415

1.72

6.44

1.4

13.32

12.83

pmol/l

0.61

359

Continuous positive airway pressure

115

2.61

6.43

1.4

1.5

18.96

14.64

pmol/l

0.59

Heartburn

147

2.53

6.42

1.7

1.6

14.50

15.19

pmol/l

0.28

124

Other diseases of pleura

104

525

1.72

6.38

1.2

1.4

16.68

15.95

pmol/l

0.25

429

Shoulder lesions

187

740

1.52

6.38

1.6

1.4

14.68

14.91

pmol/l

0.22

151

627

Deviated nasal septum

411

1.87

6.37

1.2

1.4

14.20

15.36

pmol/l

1.09

350

Thyroid crisis or storm

+∞

6.32

2.8

0.0

38.50

—

pmol/l

—

Presence of other functional implants

145

624

1.59

6.31

1.4

1.5

16.72

14.94

pmol/l

2.57

107

520

Diseases of the ear and mastoid process

308

1116

1.38

6.30

1.4

14.46

14.59

pmol/l

0.15

260

955

Alcohol dependence

323

1.99

6.27

1.3

1.5

13.86

15.40

pmol/l

1.32

275

Neuromuscular dysfunction of bladder

103

2.83

6.25

1.5

1.4

14.98

15.34

pmol/l

0.11

Presence of cardiac and vascular implants and grafts

395

1.77

6.22

1.4

1.5

20.38

15.32

pmol/l

1.69

326

Other diseases of the digestive system

422

1.85

6.22

1.4

17.01

15.72

pmol/l

0.28

349

Arthropathies

244

859

1.44

6.18

1.4

14.19

14.54

pmol/l

0.45

207

725

Finngen Rheumatological endpoints

254

1018

1.42

6.12

1.4

14.93

14.31

pmol/l

0.55

222

851

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

2.97

6.10

1.4

1.6

15.90

15.27

pmol/l

0.18

Eating disorder

157

2.43

6.07

1.2

1.4

12.34

13.50

pmol/l

0.83

133

Migraine, single triptan purchase ok & required. ICD-code if available is included

223

1051

1.44

6.03

1.4

13.56

14.72

pmol/l

2.60

188

897

Triptan medication for migraine, single purchase ok

223

1051

1.44

6.03

1.4

13.56

14.72

pmol/l

2.60

188

897

Acute renal failure

268

2.06

5.96

1.2

1.5

17.95

16.23

pmol/l

0.35

220

Injuries to the hip and thigh

122

677

1.62

5.95

1.5

1.4

15.28

15.59

pmol/l

0.18

105

557

Flat foot [pes planus] (acquired)

129

2.57

5.94

1.3

1.7

14.63

15.85

pmol/l

0.50

112

Angina pectoris

120

485

1.64

5.91

1.4

1.5

15.18

15.20

pmol/l

0.01

397

Impingement syndrome of shoulder

303

1.99

5.90

1.5

1.4

14.90

15.22

pmol/l

0.16

264

Diseases of the skin and subcutaneous tissue

254

903

1.41

5.88

1.4

15.02

14.68

pmol/l

0.24

212

768

All influenza

366

1.89

5.87

1.5

16.93

14.80

pmol/l

0.56

302

Factors influencing health status and contact with health services

124

2.19

5.85

1.5

1.7

16.80

14.99

pmol/l

0.44

108

Fall on and from stairs and steps

410

1.83

5.82

1.4

1.5

14.30

15.61

pmol/l

1.19

338

Congenital malformations, deformations and chromosomal abnormalities

166

1053

1.50

5.79

1.6

1.4

14.51

14.35

pmol/l

0.18

146

894

Ocular pain

131

2.53

5.77

1.3

1.5

14.68

14.94

pmol/l

0.09

111

Other and unspecified disorders of skin and subcutaneous tissue

3.08

5.76

1.5

1.6

15.22

14.17

pmol/l

0.27

Other external causes of accidental injury

215

743

1.45

5.76

1.3

1.5

15.39

14.44

pmol/l

0.58

177

651

Cerebrovascular diseases

173

803

1.50

5.74

1.4

16.19

15.24

pmol/l

0.58

146

662

Necrosis of pulp, including avohilmo

161

1062

1.50

5.72

1.5

1.4

13.89

14.62

pmol/l

1.06

139

902

Spondylolisthesis/Spondylolysis

239

2.10

5.71

1.5

14.62

15.89

pmol/l

0.66

205

Subjective visual disturbances

420

1.81

5.71

1.5

1.4

14.06

15.40

pmol/l

1.37

351

Reimbursement for rheumatic diseases

155

1021

1.51

5.71

1.4

1.5

14.68

14.89

pmol/l

0.22

130

854

Hyperkinetic disorders

259

2.04

5.70

1.4

1.5

13.14

13.84

pmol/l

0.54

224

Eating disorders

187

2.25

5.70

1.2

1.4

12.15

13.80

pmol/l

1.61

157

Pain in thoracic spine

220

2.14

5.67

1.7

1.6

14.24

15.85

pmol/l

0.95

189

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

182

1134

1.46

5.67

1.6

1.4

14.37

14.55

pmol/l

0.21

160

962

Other diseases of upper respiratory tract

277

1047

1.38

5.65

1.5

1.4

14.48

14.78

pmol/l

0.42

226

885

Tonsillectomy and adenotomy

165

764

1.50

5.65

1.6

1.4

14.98

13.89

pmol/l

0.74

139

662

Diaphragmatic hernia

540

1.71

5.62

1.5

14.90

15.98

pmol/l

1.34

445

Alzheimer’s disease (Late onset), excluding more controls

2.93

5.58

1.4

1.7

17.03

17.05

pmol/l

0.01

Abnormal findings on diagnostic imaging of lung

111

649

1.62

5.55

1.4

16.35

15.40

pmol/l

0.42

545

Other viral diseases, including avohilmo

110

673

1.62

5.52

1.4

1.5

14.04

14.22

pmol/l

0.14

572

Other arthrosis

131

557

1.58

5.52

1.3

1.4

14.97

15.13

pmol/l

0.12

110

465

Alzheimer’s disease (Atypical or mixed)

109

2.63

5.50

1.4

18.05

16.05

pmol/l

1.26

Other cataract

107

483

1.65

5.49

1.5

15.67

15.52

pmol/l

0.09

412

Accidents

213

743

1.44

5.46

1.3

1.5

15.38

14.44

pmol/l

0.57

175

651

Hernia

243

1163

1.39

5.44

1.4

14.83

14.93

pmol/l

0.11

206

971

Spondyloarthritis

244

2.05

5.43

1.4

1.5

14.35

14.55

pmol/l

0.12

203

Dental operations

135

440

1.58

5.42

1.6

1.3

15.80

15.07

pmol/l

0.39

113

378

Parkinson's disease, strict definition, excluding more controls

2.99

5.41

1.3

1.5

13.94

16.30

pmol/l

1.52

Cholelithiasis, broad definition with cholecystitis

223

1055

1.41

5.39

1.4

14.93

14.71

pmol/l

0.20

183

883

Early onset COPD, excluding more controls

192

2.19

5.37

1.3

1.5

14.32

14.86

pmol/l

0.37

159

Asthma and allergy

177

2.24

5.36

1.4

1.5

13.50

13.87

pmol/l

0.26

150

Viral and other specified intestinal infections

334

1.87

5.34

1.4

1.5

14.15

13.89

pmol/l

0.12

289

Diseases of oral cavity, salivary glands and jaws

129

419

1.59

5.31

1.6

1.3

16.04

15.16

pmol/l

0.48

108

355

Asthma and allergy, excluding more controls

178

2.22

5.30

1.4

1.5

13.50

13.72

pmol/l

0.15

150

Septicaemia

548

1.65

5.28

1.3

1.5

15.78

15.56

pmol/l

0.09

444

Dermatophytosis

181

2.22

5.27

1.4

1.5

14.83

16.13

pmol/l

0.59

151

Unspecific neurodegenerative disorder

355

1.72

5.26

1.4

1.5

16.53

16.78

pmol/l

0.13

285

Dental caries, including avohilmo

176

610

1.48

5.25

1.6

1.4

16.03

15.17

pmol/l

0.38

138

519

Other septicaemia

497

1.69

5.24

1.2

1.5

15.78

15.59

pmol/l

0.07

403

Other specified/unspecified arthritis

388

1.81

5.24

1.4

1.5

14.11

15.28

pmol/l

0.86

317

Caries of dentine, including avohilmo

189

664

1.46

5.23

1.6

1.4

15.97

15.13

pmol/l

0.42

152

562

Soft tissue disorders related to use, overuse and pressure

403

1.79

5.22

1.3

1.4

15.52

15.35

pmol/l

0.04

344

Dementia

372

1.69

5.16

1.4

1.5

16.15

16.60

pmol/l

0.28

303

Sequelae of injuries, of poisoning and of other consequences of external causes

347

1.85

5.15

1.4

1.5

15.50

15.00

pmol/l

0.09

295

Diseases of the eye and adnexa

206

723

1.43

5.15

1.6

1.4

14.26

14.49

pmol/l

0.22

175

623

Internal derangement of knee

571

1.65

5.14

1.3

1.4

14.54

14.89

pmol/l

0.28

473

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

112

699

1.58

5.14

1.4

1.5

13.49

14.20

pmol/l

0.82

605

Cervicocranial syndrome

145

2.35

5.14

1.2

1.5

13.86

15.29

pmol/l

0.71

126

Ulcer of lower limb, not elsewhere classified

164

2.26

5.12

1.4

15.61

16.37

pmol/l

0.26

133

Other mental disorders due to brain damage and dysfunction and to physical disease

133

2.41

5.12

1.3

1.5

14.63

16.35

pmol/l

0.80

107

Acute laryngitis and tracheitis

187

2.17

5.09

1.2

1.5

13.53

14.01

pmol/l

0.36

158

Dementia, including avohilmo

404

1.66

5.07

1.4

1.5

15.93

16.47

pmol/l

0.37

331

Undetermined asthma, excluding more controls

171

2.23

5.07

1.6

1.5

14.28

14.56

pmol/l

0.17

136

Cholecystectomy

184

1094

1.43

5.07

1.4

15.09

14.85

pmol/l

0.18

152

915

Dentofacial anomalies [including malocclusion]

202

1123

1.41

5.06

1.7

1.4

13.62

14.53

pmol/l

2.00

174

946

Gingivitis and periodontal diseases

249

936

1.37

5.03

1.5

1.4

15.38

14.92

pmol/l

0.26

197

802

Disorders of choroid and retina

194

957

1.42

5.01

1.4

15.30

15.01

pmol/l

0.32

161

803

Undetermined asthma

172

2.21

5.00

1.6

1.5

14.28

14.76

pmol/l

0.34

135

Other arthritis (FG)

468

1.71

5.00

1.4

14.15

14.98

pmol/l

0.61

381

Neoplasms

203

750

1.42

4.99

1.6

1.4

14.28

14.06

pmol/l

0.24

178

634

Autoimmune diseases excluding thyroid diseases, strict definition

150

542

1.51

4.98

1.3

1.2

14.01

13.96

pmol/l

0.05

132

459

Cholelithiasis

213

1042

1.40

4.97

1.5

1.4

14.67

14.73

pmol/l

0.05

173

872

Other respiratory disorders and diseases

253

1.98

4.95

1.1

1.5

16.56

16.40

pmol/l

0.06

208

Other diseases of the respiratory system

253

1.98

4.95

1.1

1.5

16.56

16.40

pmol/l

0.06

208

Pregnancy examination and test

190

1.93

4.94

1.5

1.3

12.88

13.25

pmol/l

0.30

167

Asthma-related pneumonia

544

1.65

4.92

1.5

15.96

15.56

pmol/l

0.13

443

Glaucoma suspect

561

1.64

4.92

1.2

1.5

15.15

15.88

pmol/l

0.63

471

Chronic gastritis

367

1.80

4.91

1.4

14.69

15.99

pmol/l

1.28

305

Contact with and exposure to communicable diseases

567

1.64

4.89

1.4

1.5

13.74

13.68

pmol/l

0.02

485

Bacterial pneumoniae

518

1.63

4.88

1.5

1.4

16.55

14.94

pmol/l

0.67

422

Fracture of foot, except ankle

412

1.75

4.88

1.2

1.5

13.75

14.91

pmol/l

0.98

349

Glaucoma

134

755

1.51

4.87

1.3

1.5

15.49

15.68

pmol/l

0.15

110

625

Injuries to the thorax

107

679

1.58

4.86

1.5

1.4

15.86

15.17

pmol/l

0.41

561

Asthma, hospital admissions 3, pneumonia

547

1.64

4.82

1.5

15.96

15.55

pmol/l

0.14

446

Asthma-related pneumonia or sepsis

547

1.64

4.82

1.5

15.96

15.55

pmol/l

0.14

446

Other viral diseases, not elsewhere classified, including avohilmo

463

1.70

4.81

1.5

14.06

14.56

pmol/l

0.34

392

Acute sinusitis

142

872

1.48

4.79

1.6

1.4

13.99

14.51

pmol/l

0.71

120

745

Other septicaemia, including avohilmo

508

1.65

4.78

1.2

1.5

15.78

15.56

pmol/l

0.08

411

Myocardial infarction

406

1.64

4.75

1.3

1.5

16.98

15.35

pmol/l

0.58

329

Dementia in Alzheimer disease

162

2.12

4.73

1.4

1.5

17.77

16.78

pmol/l

0.48

123

Pain and other conditions associated with female genital organs and menstrual cycle

345

1.75

4.72

1.4

13.49

14.02

pmol/l

0.50

291

Injuries to the ankle and foot

197

1209

1.39

4.72

1.3

1.4

14.03

14.60

pmol/l

0.55

153

1037

Zoster [herpes zoster]

279

1.90

4.70

1.3

1.4

15.35

16.15

pmol/l

0.39

228

Adhesive capsulitis of shoulder

217

2.03

4.70

1.6

1.5

14.21

15.43

pmol/l

0.75

186

Conduction disorders

272

1.83

4.69

1.1

1.5

16.35

14.66

pmol/l

1.06

226

Other disorders of eye and adnexa

231

2.00

4.68

1.2

1.5

14.95

15.00

pmol/l

0.02

193

Papulosquamous disorders

100

632

1.59

4.66

1.6

1.4

14.61

15.30

pmol/l

0.74

526

Fracture of lumbar spine and pelvis

322

1.83

4.65

1.4

1.5

14.39

16.31

pmol/l

1.54

262

Use of other anti-dementia drugs

263

1.84

4.63

1.5

1.4

17.03

16.67

pmol/l

0.19

207

Use of memantine

263

1.84

4.63

1.5

1.4

17.03

16.67

pmol/l

0.19

207

Any dementia, excluding more controls

272

1.77

4.62

1.4

16.45

17.03

pmol/l

0.29

222

Acute tubulo-interstitial nephritis

159

933

1.44

4.59

1.5

1.4

15.91

14.68

pmol/l

1.60

134

771

Excessive, frequent and irregular menstruation

120

414

1.55

4.56

1.5

1.4

14.03

14.46

pmol/l

0.45

347

Other enthesopathies

459

1.68

4.53

1.5

1.4

13.79

14.89

pmol/l

1.04

392

Other and unspecified dermatitis

140

958

1.46

4.52

1.5

1.4

14.21

14.89

pmol/l

0.91

115

815

Viral and other specified intestinal infections, including avohilmo

478

1.65

4.52

1.3

1.5

14.39

14.01

pmol/l

0.22

409

Fracture of rib(s), sternum and thoracic spine

422

1.71

4.51

1.4

1.5

15.50

15.74

pmol/l

0.14

346

Other noninfective gastroenteritis and colitis

392

1.74

4.51

1.4

1.5

14.00

15.46

pmol/l

1.38

318

Other systemic involvement of connective tissue

460

1.68

4.50

1.3

1.4

15.77

15.64

pmol/l

0.06

375

Bacterial pneumonia, not elsewhere classified

489

1.62

4.49

1.5

1.4

15.88

15.03

pmol/l

0.32

399

Diseases of peritoneum

129

2.33

4.49

1.4

1.6

17.49

14.80

pmol/l

0.30

109

Second line medication for Crohn's disease

150

1040

1.44

4.49

1.5

1.4

14.79

14.72

pmol/l

0.06

128

876

Dermatitis

164

1131

1.42

4.49

1.5

1.4

14.31

14.84

pmol/l

0.75

132

956

Strabismus

423

1.70

4.43

1.3

1.5

14.67

14.83

pmol/l

0.10

351

Cervicalgia

285

1.86

4.43

1.2

1.5

15.09

15.68

pmol/l

0.24

240

Stroke, including SAH

136

661

1.48

4.40

1.4

15.29

15.68

pmol/l

0.33

110

554

L04AX Other immunosuppressants

144

997

1.45

4.37

1.5

1.4

14.68

14.78

pmol/l

0.09

123

835

Other diseases of blood and blood-forming organs, wide

338

1.78

4.33

1.5

14.42

15.85

pmol/l

1.06

278

Disease of hard tissues of teeth, NOS

120

411

1.53

4.31

1.4

1.3

15.07

15.10

pmol/l

0.02

101

347

Specific development disorders of scholastic skills

3.22

4.31

1.7

1.3

13.48

12.44

pmol/l

0.49

Acute and transient psychotic disorders

164

2.14

4.30

1.4

1.5

13.03

15.09

pmol/l

1.28

140

Other disorders of ear

225

1078

1.35

4.30

1.4

14.98

14.81

pmol/l

0.16

180

905

Alcohol abuse, main dg, excluding more controls

151

2.19

4.29

1.2

1.4

13.75

16.11

pmol/l

0.84

130

Other disorders of nervous system

2.79

4.28

1.7

1.5

13.26

16.06

pmol/l

0.92

Benign neoplasm: Colon, unspecified

332

1.78

4.28

1.5

15.05

16.54

pmol/l

1.23

273

Other viral diseases

496

1.63

4.26

1.4

1.5

14.12

14.55

pmol/l

0.33

422

Disorders of vestibular function (Vertigo)

120

785

1.49

4.26

1.4

14.77

15.38

pmol/l

0.66

654

Injuries to the elbow and forearm

191

1193

1.37

4.26

1.4

15.25

14.61

pmol/l

0.76

157

1008

Viral infections characterized by skin and mucous membrane lesions

105

686

1.53

4.25

1.3

1.4

14.56

15.09

pmol/l

0.47

564

Other disorders of the musculoskeletal system and connective tissue

212

1.99

4.24

1.7

1.5

14.37

15.47

pmol/l

0.60

178

Ingrowing nail

2.85

4.22

1.6

1.3

16.04

15.76

pmol/l

0.05

Other diseases of hard tissues of teeth

122

417

1.52

4.22

1.5

1.3

15.34

15.14

pmol/l

0.08

353

Injuries to the neck

378

1.72

4.22

1.4

1.5

14.16

15.00

pmol/l

0.60

319

Rotator cuff syndrome

140

662

1.46

4.22

1.5

1.4

14.52

15.05

pmol/l

0.58

116

564

Excessive earwax

151

961

1.42

4.21

1.4

15.52

15.07

pmol/l

0.47

120

801

Other skin changes

305

1.81

4.20

1.4

1.5

15.66

16.02

pmol/l

0.16

247

Other acute lower respiratory infections

131

855

1.46

4.19

1.4

14.77

15.04

pmol/l

0.22

106

712

Coxarthrosis [arthrosis of hip](FG)

123

568

1.49

4.16

1.3

1.5

15.66

15.16

pmol/l

0.43

104

471

Other and unspecified tonsillitis

433

1.61

4.15

1.5

1.4

13.39

14.37

pmol/l

1.11

373

Acute gastritis

2.60

4.13

1.9

1.4

13.94

14.79

pmol/l

0.61

Coxibs

204

1.75

4.13

1.2

1.5

14.14

15.01

pmol/l

0.68

178

Sequelae of cerebrovascular disease

394

1.65

4.11

1.3

1.4

16.76

16.17

pmol/l

0.13

319

Bacterial pneumonia (organism specified)

101

596

1.54

4.10

1.5

1.4

16.46

15.30

pmol/l

0.45

486

Intestinal stricture

442

1.65

4.09

1.3

1.4

15.30

16.00

pmol/l

0.53

366

Chronic sinusitis

106

700

1.51

4.09

1.4

14.31

14.80

pmol/l

0.54

586

Striking against or struck by other objects

534

1.59

4.08

1.4

1.5

14.42

14.76

pmol/l

0.13

454

Stroke, excluding SAH

125

611

1.48

4.08

1.4

15.44

15.81

pmol/l

0.28

513

Noninfective enteritis and colitis

116

784

1.48

4.01

1.4

14.20

14.94

pmol/l

0.90

658

Other and unspecified local infections of skin and subcutaneous tissue

130

2.24

3.98

1.4

17.64

15.42

pmol/l

0.18

112

Sensorineural hearing loss

175

843

1.38

3.98

1.4

15.18

15.16

pmol/l

0.01

138

707

Exposure to unspecified factor

262

1370

1.30

3.96

1.3

1.4

14.19

14.74

pmol/l

0.53

211

1167

Persons with potential health hazards related to communicable diseases

105

692

1.51

3.95

1.4

1.5

13.69

14.00

pmol/l

0.12

596

Disorders of lens

150

654

1.42

3.95

1.5

14.98

15.02

pmol/l

0.02

122

554

Conductive and sensorineural hearing loss

186

903

1.37

3.94

1.4

15.02

15.03

pmol/l

0.01

147

756

Unspecified fall

126

854

1.45

3.92

1.2

1.4

14.26

15.15

pmol/l

1.14

101

717

Pain associated with micturition

184

2.02

3.92

1.4

1.5

13.50

15.30

pmol/l

1.15

151

Other viral diseases, not elsewhere classified

289

1.80

3.92

1.5

14.13

14.62

pmol/l

0.34

245

Sequelae of external causes of morbidity and mortality

402

1.67

3.91

1.4

1.5

14.35

15.91

pmol/l

1.57

328

Other strabismus

363

1.71

3.90

1.4

1.5

14.88

14.44

pmol/l

0.35

304

Acute pancreatitis

255

1.85

3.87

1.4

1.5

14.17

15.99

pmol/l

1.10

216

Disorders of psychological development

177

2.00

3.87

1.5

13.22

13.84

pmol/l

0.43

144

Abnormal findings on diagnostic imaging of other body structures

206

1.95

3.85

1.4

1.5

14.71

15.23

pmol/l

0.30

173

Use of pramipexole

336

1.73

3.85

1.3

1.5

14.03

15.95

pmol/l

1.53

275

Any dementia

344

1.61

3.82

1.4

1.5

16.49

16.77

pmol/l

0.15

275

Maternal care for other conditions predominantly related to pregnancy

409

1.65

3.82

1.2

1.4

13.25

13.40

pmol/l

0.12

346

Fissure and fistula of anal and rectal regions

322

1.74

3.82

1.6

1.5

15.09

15.84

pmol/l

0.37

268

Diseases of pulp and periapical tissues and dental caries

150

541

1.42

3.81

1.6

1.4

15.40

15.11

pmol/l

0.14

118

458

Peripheral artery disease

415

1.58

3.78

1.6

1.4

17.31

16.05

pmol/l

0.37

342

Urinary track infection

186

681

1.37

3.77

1.5

1.4

14.61

14.01

pmol/l

0.62

156

583

COPD (mode)

284

1.70

3.76

1.2

1.4

16.29

15.33

pmol/l

0.80

238

Misadventures to patients during surgical and medical care

208

1.93

3.75

1.4

1.5

14.51

15.83

pmol/l

0.59

177

Ovarian cyst

104

392

1.52

3.75

1.4

14.06

14.54

pmol/l

0.48

327

Cholangitis (primary sclerosing, PSC)

2.65

3.73

1.4

1.6

13.60

14.90

pmol/l

0.63

Cervicobrachial syndrome

310

1.75

3.71

1.3

1.4

14.56

15.39

pmol/l

0.38

265

Supplementary factors related to causes of morbidity and mortality classified elsewhere

517

1.57

3.71

1.4

1.5

13.85

15.35

pmol/l

1.59

426

Other retinal disorders

144

778

1.41

3.71

1.6

1.4

15.69

15.34

pmol/l

0.32

119

645

Other diseases of anus and rectum

423

1.63

3.67

1.3

1.5

14.38

16.02

pmol/l

1.63

356

Polyarthrosis

279

1.75

3.66

1.4

1.6

15.26

15.89

pmol/l

0.33

227

Impacted cerumen

142

2.12

3.64

1.7

1.5

16.01

15.28

pmol/l

0.30

115

Transport accidents

118

678

1.45

3.63

1.4

1.5

13.67

14.42

pmol/l

1.37

106

591

Ectopic pregnancy

320

1.72

3.62

1.5

1.4

14.06

14.52

pmol/l

0.34

269

Retinal detachments and breaks

481

1.58

3.61

1.2

1.4

15.18

15.94

pmol/l

0.57

395

Spondylopathies (FG)

211

1.90

3.61

1.4

1.6

14.54

15.23

pmol/l

0.29

175

Myocardial infarction, strict

375

1.57

3.60

1.3

1.5

16.05

15.43

pmol/l

0.19

306

Gonarthrosis, primary, with knee surgery

129

705

1.43

3.59

1.3

1.5

15.62

15.51

pmol/l

0.08

107

579

Migraine without aura and triptan purchases

306

1.74

3.59

1.3

1.4

13.33

14.18

pmol/l

0.73

259

Other and unspecified nerve root and plexus disorders, also in other diseases

299

1.74

3.57

1.3

1.5

13.94

15.28

pmol/l

0.87

250

Diplopia

191

1.94

3.56

1.3

1.5

14.89

16.04

pmol/l

0.51

164

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

183

1.96

3.56

1.8

1.5

14.57

14.43

pmol/l

0.06

154

Diseases of middle ear and mastoid

150

886

1.38

3.56

1.4

14.30

14.50

pmol/l

0.20

130

751

Diseases of inner ear

132

897

1.41

3.55

1.4

14.86

15.24

pmol/l

0.36

109

749

Postprocedural musculoskeletal disorders, not elsewhere classified

2.45

3.55

1.6

14.28

15.29

pmol/l

0.35

Candidiasis

234

1.84

3.54

1.7

1.5

14.52

15.10

pmol/l

0.33

194

Acute pancreatitis (for exclusion)

263

1.79

3.54

1.4

1.5

14.17

15.79

pmol/l

0.96

219

Complications of internal orthopaedic prosthetic devices, implants and grafts

315

1.72

3.53

1.2

1.5

15.83

16.56

pmol/l

0.40

259

Diseases of external ear

548

1.54

3.51

1.7

1.4

14.92

15.26

pmol/l

0.24

457

Coxarthrosis

110

484

1.47

3.48

1.3

1.5

15.73

15.38

pmol/l

0.25

404

Lichen planus

179

1.96

3.47

1.6

1.5

15.53

15.82

pmol/l

0.12

153

Transient ischemic attack

108

589

1.46

3.46

1.5

1.4

16.16

15.98

pmol/l

0.06

492

Mycoses, including avohilmo

235

1389

1.29

3.42

1.4

14.18

14.73

pmol/l

0.89

196

1174

Acute peritonitis

2.77

3.42

1.4

1.6

20.28

14.48

pmol/l

0.45

Unstable angina pectoris

313

1.63

3.41

1.3

1.5

15.12

15.58

pmol/l

0.28

252

Abnormalities of gait and mobility

133

2.11

3.38

1.3

1.5

14.70

15.19

pmol/l

0.21

110

Acute bronchitis

637

1.48

3.38

1.4

14.50

15.41

pmol/l

0.93

526

Noninfectious colitis NAS

202

1.89

3.38

1.6

1.5

14.07

15.01

pmol/l

0.54

171

Acetic acid derivatives and related substances

202

1.67

3.37

1.3

1.5

16.53

15.02

pmol/l

0.44

176

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

3.11

3.37

1.4

1.7

12.56

14.83

pmol/l

—

Haemorrhoids and perianal venous thrombosis

502

1.54

3.37

1.6

1.5

13.55

15.77

pmol/l

3.94

423

Other sleep disorders

140

2.08

3.36

1.4

1.6

12.26

15.95

pmol/l

2.03

115

Arthrosis

161

646

1.37

3.34

1.4

14.46

14.94

pmol/l

0.44

136

538

Diseases of liver

515

1.54

3.34

1.2

1.5

14.06

15.61

pmol/l

1.89

424

Sarcoidosis

189

1.91

3.32

1.2

1.5

19.72

15.10

pmol/l

0.63

163

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

226

1104

1.29

3.32

1.5

1.4

14.51

14.76

pmol/l

0.29

187

925

Certain disorders involving the immune mechanism

291

1.72

3.32

1.3

1.5

20.58

15.11

pmol/l

0.93

244

Other local infections of skin and subcutaneous tissue

141

2.06

3.31

1.4

1.5

17.64

15.21

pmol/l

0.20

121

Varicose veins

143

784

1.38

3.31

1.5

1.4

15.03

15.29

pmol/l

0.22

122

656

Chondrocostal junction syndrome [Tietze]

2.93

3.30

1.3

1.6

14.50

14.68

pmol/l

—

Certain infectious and parasitic diseases, including avohilmo

176

655

1.35

3.28

1.5

16.09

14.37

pmol/l

1.10

150

551

Chronic periodontitis, complicated

129

904

1.39

3.28

1.5

1.4

14.94

15.08

pmol/l

0.10

767

Open wound of wrist and hand

105

704

1.44

3.26

1.3

1.4

14.78

14.72

pmol/l

0.02

595

L04AA Selective immunosuppressants

346

1.65

3.25

1.3

1.6

16.26

14.87

pmol/l

0.35

290

Diagnoses used for exclusion with ILD

346

1.65

3.25

1.2

1.5

17.55

15.39

pmol/l

0.42

286

Type of accident

479

1.55

3.24

1.3

1.5

13.62

15.38

pmol/l

1.90

394

Abnormal involuntary movements

191

1.89

3.23

1.5

1.6

14.77

15.23

pmol/l

0.16

165

Persons encountering health services for other counselling and medical advice, not elsewhere classified

263

1102

1.27

3.22

1.4

14.56

14.80

pmol/l

0.20

229

928

Periapical abscess

110

773

1.42

3.21

1.7

1.4

15.45

14.77

pmol/l

0.23

655

Methotrexate

199

1.86

3.19

1.4

1.5

15.07

14.91

pmol/l

0.07

161

Genitourinary diseases

119

417

1.43

3.19

1.4

1.5

13.90

14.95

pmol/l

1.16

363

Endometriosis

381

1.48

3.19

1.4

14.30

14.61

pmol/l

0.22

317

Urticaria and erythema

667

1.46

3.18

1.5

1.4

14.97

14.73

pmol/l

0.07

561

Injury, poisoning and certain other consequences of external causes

137

493

1.39

3.17

1.4

15.19

14.46

pmol/l

0.40

114

431

Other and unspecified polyneuropathies, also in other diseases

229

1.79

3.14

1.1

1.5

15.74

16.49

pmol/l

0.28

192

Other epidermal thickening

2.97

3.13

2.2

1.4

14.02

14.19

pmol/l

0.05

Zoster [herpes zoster], including avohilmo

127

887

1.38

3.12

1.3

1.5

15.04

15.31

pmol/l

0.23

104

731

Other and unspecified myopathies

2.25

3.12

1.2

1.5

14.77

15.91

pmol/l

0.36

Thoracic aortic aneurysm

138

2.03

3.10

1.5

1.4

16.08

15.99

pmol/l

0.02

118

Candidiasis, including avohilmo

557

1.49

3.09

1.4

14.16

14.88

pmol/l

0.64

455

Nontraumatic intracranial haemmorrhage

245

1.76

3.09

1.3

1.4

16.18

16.38

pmol/l

0.07

199

Other and unspecified injuries of head

105

2.20

3.08

1.1

1.6

18.56

15.26

pmol/l

1.26

Vasomotor and allergic rhinitis

632

1.45

3.08

1.4

13.50

14.53

pmol/l

1.48

544

Dislocation, sprain and strain of joints and ligaments at neck level

253

1.74

3.07

1.5

1.4

13.26

14.58

pmol/l

0.96

214

Sequelae with surgical and medical care as external cause

306

1.67

3.06

1.3

1.5

14.08

16.05

pmol/l

1.69

253

Gonarthrosis [arthrosis of knee](FG)

164

705

1.34

3.06

1.3

1.4

15.12

14.78

pmol/l

0.31

146

585

Recurrent aphthous stomatitis , including avohilmo

224

1.79

3.05

1.2

1.5

14.45

14.98

pmol/l

0.27

190

Fracture of shoulder and upper arm

574

1.48

3.05

1.4

14.26

15.72

pmol/l

1.72

472

Primary gonarthrosis, bilateral

115

686

1.40

3.05

1.3

1.5

15.05

15.51

pmol/l

0.45

102

564

Other diseases of stomach and duodenum

2.59

3.04

1.2

1.6

15.17

15.12

pmol/l

0.01

Other bacterial intestinal infections, including avohilmo

353

1.62

3.03

1.2

1.5

15.64

15.29

pmol/l

0.07

289

Carpal tunnel syndrome

147

947

1.35

3.02

1.5

1.4

14.12

15.08

pmol/l

1.68

123

792

Benign neoplasm of other and ill-defined parts of digestive system

262

1.72

3.01

1.7

1.5

16.01

15.94

pmol/l

0.03

216

Disorders of sclera, cornea, iris and ciliary body

131

962

1.36

2.99

1.2

1.4

14.50

14.89

pmol/l

0.42

105

810

Disorders of refraction and accommodation

487

1.52

2.98

1.6

1.5

14.11

14.55

pmol/l

0.30

407

Acute nasopharyngitis (common cold)

126

2.05

2.95

1.2

1.3

12.79

15.61

pmol/l

1.43

107

Mental and behavioural disorders due to tobacco

114

2.11

2.94

2.0

1.4

13.51

15.62

pmol/l

0.99

100

Ischaemic Stroke, excluding all haemorrhages

111

581

1.41

2.93

1.5

1.4

15.16

15.98

pmol/l

0.77

484

Paracetamol or NSAID medication

1.89

2.91

1.5

1.6

13.89

14.59

pmol/l

0.40

Vitamin B12 deficiency anaemia

108

2.13

2.90

1.5

1.6

14.05

15.06

pmol/l

0.50

Other and unspecified epidermal thickening

3.73

2.88

2.6

1.6

14.03

14.74

pmol/l

—

Meniscus derangement

121

580

1.39

2.88

1.4

14.42

15.09

pmol/l

0.69

105

484

Abrasion of teeth

641

1.44

2.86

1.4

13.82

15.03

pmol/l

1.45

545

Inflammatory diseases of female pelvic organs

190

1007

1.29

2.86

1.6

1.4

13.01

14.50

pmol/l

5.67

151

852

Other diseases of lip and oral mucosa

107

767

1.40

2.84

1.6

1.4

13.77

15.18

pmol/l

1.89

637

Other noninflammatory disorders of vulva and perineum

157

1.92

2.84

1.5

1.3

13.92

14.86

pmol/l

0.46

124

Smoking dependency

116

2.08

2.82

2.0

1.4

13.51

15.55

pmol/l

0.95

102

Persons encountering health services for specific procedures, not carried out

116

2.08

2.82

1.1

1.6

14.37

14.28

pmol/l

0.02

102

Localized swelling, mass and lump of skin and subcutaneous tissue

504

1.49

2.81

1.5

1.4

15.31

15.30

pmol/l

0.00

416

Injuries to the wrist and hand

253

1347

1.25

2.81

1.4

14.26

14.70

pmol/l

0.41

215

1135

Exposure to other specified factors

201

1357

1.27

2.77

1.5

1.4

14.08

14.66

pmol/l

0.89

167

1152

Open wound of head

117

802

1.37

2.77

1.2

1.5

15.63

15.26

pmol/l

0.11

687

Disorders of vitreous body and globe

121

841

1.36

2.75

1.4

1.5

15.00

15.37

pmol/l

0.36

105

693

Abnormal findings on antenatal screening of mother

145

1.94

2.74

1.5

1.4

12.04

13.07

pmol/l

0.94

123

Familial hypercholesterolemia

138

1.96

2.74

1.7

1.3

12.80

16.41

pmol/l

3.06

111

245

1.68

2.70

1.5

1.4

18.29

17.00

pmol/l

0.59

193

Benign neoplasm of mouth and pharynx

139

1.95

2.69

2.1

1.5

17.41

15.62

pmol/l

0.92

116

Injuries to the shoulder and upper arm

204

1243

1.27

2.69

1.4

14.18

15.06

pmol/l

1.74

169

1046

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

224

1394

1.25

2.67

1.3

1.4

14.20

14.75

pmol/l

0.88

189

1176

Gonarthrosis,primary

193

910

1.28

2.66

1.3

1.4

15.27

15.12

pmol/l

0.14

171

757

Hernia of abdominal wall

677

1.40

2.64

1.5

1.4

14.17

15.30

pmol/l

1.14

558

Coxarthrosis, primary

125

771

1.35

2.62

1.3

1.5

15.85

15.57

pmol/l

0.22

105

637

Other diseases of peritoneum

2.56

2.61

1.4

1.7

12.53

15.14

pmol/l

—

Contraceptive management

100

499

1.40

2.61

1.5

1.4

13.85

14.39

pmol/l

0.56

434

Aortic aneurysm

209

1.74

2.60

1.5

1.4

16.20

15.90

pmol/l

0.12

173

Early lumbar disc prolapse, operated

141

1.92

2.59

1.5

1.7

14.09

14.52

pmol/l

0.15

120

Other shoulder lesions

134

1.95

2.59

1.7

1.6

16.53

15.06

pmol/l

0.60

117

In situ neoplasms

680

1.40

2.58

1.4

14.82

15.38

pmol/l

0.53

559

Atopic dermatitis

155

949

1.30

2.56

1.5

1.4

13.62

14.46

pmol/l

1.54

124

821

Erosion of teeth , including avohilmo

466

1.48

2.56

1.4

1.5

12.08

14.62

pmol/l

4.80

397

COPD

476

1.43

2.55

1.3

1.4

15.68

pmol/l

0.00

391

Hyperplasia of prostate

151

1.68

2.55

1.3

1.4

14.63

16.51

pmol/l

0.77

130

Polyneuropathies and other disorders of the peripheral nervous system

276

1.63

2.54

1.2

1.5

15.40

16.21

pmol/l

0.35

233

Diabetes mellitus in pregnancy

450

1.40

2.53

1.3

1.4

12.82

13.22

pmol/l

0.48

385

Other bacterial intestinal infections

261

1.65

2.53

1.3

1.4

16.08

15.46

pmol/l

0.10

217

Fall involving bed

3.24

2.52

1.2

2.0

15.88

15.10

pmol/l

—

Sulfasalazine

436

1.49

2.50

1.4

14.14

14.44

pmol/l

0.25

357

Valvular operations

115

2.00

2.50

1.3

1.5

16.68

14.29

pmol/l

1.28

Special screening examination for infectious and parasitic diseases

189

1.66

2.47

1.7

1.5

14.19

14.39

pmol/l

0.07

167

Superficial injury of head

397

1.51

2.45

1.6

1.5

14.49

15.46

pmol/l

0.56

328

Right hemicolectomy

2.46

2.45

1.6

14.98

14.95

pmol/l

0.01

Degenerative macular diseases

130

1.93

2.44

1.3

1.5

14.82

15.61

pmol/l

0.37

105

Stomatitis and related lesions

334

1.56

2.44

1.4

1.5

14.44

14.94

pmol/l

0.30

284

Chronic pancreatitis

138

1.89

2.40

1.3

1.6

16.78

16.53

pmol/l

0.06

117

Other diseases of intestine

189

1.75

2.40

1.5

1.6

14.74

16.88

pmol/l

1.02

159

Maternal care for other known or suspected fetal problems

313

1.46

2.39

1.4

1.3

13.01

13.10

pmol/l

0.08

273

Other chronic obstructive pulmonary disease, including avohilmo

104

627

1.36

2.38

1.3

1.4

15.28

15.83

pmol/l

0.46

512

Other medical care

103

634

1.36

2.38

1.3

1.5

17.26

15.20

pmol/l

0.95

508

Other chronic obstructive pulmonary disease

453

1.43

2.38

1.3

1.4

15.73

15.78

pmol/l

0.02

375

322

1.52

2.37

1.6

1.5

17.90

16.66

pmol/l

0.80

261

Ganglion

313

1.57

2.37

1.7

1.4

14.43

14.73

pmol/l

0.19

265

Superficial injury of forearm

146

1.85

2.36

1.4

1.6

14.33

14.95

pmol/l

0.26

122

Ventral hernia

337

1.55

2.36

1.6

1.5

14.86

16.14

pmol/l

0.69

273

Disorders of vitreous body

115

821

1.33

2.34

1.3

1.5

15.00

15.41

pmol/l

0.39

100

679

Inflammatory disease of uterus

267

1.61

2.34

1.2

1.5

12.49

14.14

pmol/l

2.18

222

Other female pelvic inflammatory diseases

291

1.58

2.32

2.3

1.5

12.98

15.02

pmol/l

2.88

243

Temporomandibular joint disorders, including avohilmo

124

913

1.32

2.32

1.7

1.4

13.42

14.34

pmol/l

1.45

106

783

Colonic or urogenital fistula

411

1.49

2.32

1.6

1.5

15.14

15.61

pmol/l

0.24

339

Operations 2 for CAVS

333

1.53

2.32

1.4

15.14

17.11

pmol/l

1.65

264

Calcific aortic valvular stenosis, diagnosis (helper)

333

1.53

2.32

1.4

15.14

17.11

pmol/l

1.65

264

Pulmonary heart disease, diseases of pulmonary circulation

460

1.46

2.32

1.3

1.4

14.73

16.16

pmol/l

1.31

380

Any event in cancer register

218

1029

1.24

2.31

1.5

1.4

14.25

14.49

pmol/l

0.30

192

865

Hallux valgus (acquired)

409

1.42

2.30

1.3

1.5

14.88

15.45

pmol/l

0.33

339

Conjunctivitis (acute, non atopic), including avohilmo

244

1207

1.22

2.29

1.3

1.4

14.26

14.82

pmol/l

0.94

204

1020

518

1.41

2.29

1.4

1.5

15.29

16.26

pmol/l

0.96

423

Calcific aortic valvular stenosis, operated

334

1.53

2.29

1.4

15.14

17.10

pmol/l

1.64

265

Calcific aortic valvular stenosis

334

1.53

2.29

1.4

15.14

17.10

pmol/l

1.64

265

Calcific aortic valvular stenosis, including rheumatic fever

334

1.53

2.28

1.4

15.14

17.10

pmol/l

1.64

265

Retention of urine

325

1.49

2.28

1.6

1.4

14.43

15.96

pmol/l

1.17

265

Dermatitis due to substances taken internally

2.23

2.27

1.8

1.5

16.03

14.46

pmol/l

0.47

Rheumatoid arthritis

430

1.44

2.26

1.2

1.5

15.57

15.41

pmol/l

0.08

351

Otitis externa

357

1.51

2.26

1.7

1.5

14.37

15.05

pmol/l

0.49

303

COPD, hospital admission 2, with asthma infections

327

1.50

2.24

1.2

1.5

15.84

16.50

pmol/l

0.32

266

False labour

392

1.39

2.24

1.4

1.3

12.88

13.37

pmol/l

0.64

338

Gonarthrosis

133

574

1.31

2.23

1.3

1.4

14.81

15.09

pmol/l

0.20

117

479

Fracture of forearm

140

978

1.29

2.21

1.5

14.96

14.93

pmol/l

0.02

114

824

Other and unspecified urticaria

335

1.53

2.20

1.5

15.96

14.66

pmol/l

0.22

281

Injuries to the knee and lower leg

289

1305

1.20

2.20

1.3

1.4

14.24

14.65

pmol/l

0.73

250

1097

Early onset COPD

264

1.59

2.19

1.3

1.5

14.32

15.71

pmol/l

0.90

220

Atherosclerosis, excluding cerebral and coronary sclerosis

383

1.44

2.19

1.6

1.4

17.46

16.28

pmol/l

0.28

311

Actinic keratosis

469

1.42

2.17

1.4

15.53

16.51

pmol/l

0.88

378

Alzheimer disease, including avohilmo

337

1.44

2.17

1.4

17.38

16.78

pmol/l

0.36

270

Achilles tendinitis

129

1.86

2.16

1.4

1.7

14.39

16.30

pmol/l

0.72

112

Other embolism and thrombosis

173

1.74

2.16

1.2

1.5

15.52

15.33

pmol/l

0.06

148

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

361

1.50

2.16

1.5

1.4

12.87

13.98

pmol/l

1.26

306

Congenital malformations and deformations of the musculoskeletal system

136

1.83

2.13

1.6

1.4

14.94

13.78

pmol/l

0.96

116

Senile cataract

122

565

1.31

2.13

1.5

15.23

15.20

pmol/l

0.01

480

Disorders of muscles

137

1.83

2.13

1.6

20.86

14.97

pmol/l

0.62

119

Recurrent dislocation of patella

2.11

2.12

1.6

1.5

13.49

13.22

pmol/l

0.12

Other inflammation of eyelid

212

1.65

2.12

1.4

1.5

14.18

15.33

pmol/l

0.68

178

Venous thromboembolism

112

821

1.31

2.11

1.3

1.4

14.90

15.49

pmol/l

0.62

677

Melanocytic naevi

529

1.40

2.10

1.6

1.4

14.61

14.79

pmol/l

0.11

431

Atopic dermatitis, strict definition with reimbursement

540

1.39

2.09

1.6

1.5

13.41

14.25

pmol/l

1.03

460

Preterm labour and delivery

496

1.41

2.08

1.5

13.91

14.09

pmol/l

0.11

424

Car occupant injured in other and unspecified transport accidents

308

1.53

2.07

1.3

1.5

13.75

15.07

pmol/l

1.13

259

Fracture of lower leg, including ankle

129

987

1.28

2.05

1.3

1.5

15.14

15.13

pmol/l

0.00

103

821

Psoriasis

440

1.43

2.04

1.5

14.25

15.45

pmol/l

1.13

362

Anomalies of dental arch relationship, including avohilmo

330

1.48

2.03

1.4

1.5

13.03

14.46

pmol/l

1.26

281

Other respiratory diseases principally affecting the interstitium

207

1.65

2.03

1.6

1.4

21.29

16.19

pmol/l

0.55

165

Bulimia nervosa (incl. atypical)

2.41

2.02

1.2

11.47

12.82

pmol/l

—

Disorders of breast

141

979

1.27

2.02

1.3

1.5

13.98

14.46

pmol/l

0.68

118

816

Algoneurodystrophy

2.51

2.01

1.3

1.6

12.49

13.88

pmol/l

0.86

Other maternal disorders predominantly related to pregnancy

159

792

1.26

2.01

1.4

13.48

14.23

pmol/l

1.44

137

671

Biomechanical lesions, not elsewhere classified

2.23

2.01

1.6

14.56

14.21

pmol/l

—

Other orthopaedic follow-up care

2.23

2.01

1.6

12.53

15.01

pmol/l

2.25

Unspecified dementia

1.91

2.00

1.4

1.5

15.27

16.51

pmol/l

0.65

Artrosis, including avohilmo

182

804

1.24

2.00

1.4

1.5

14.79

14.83

pmol/l

0.03

155

667

Crohn disease

193

1.66

1.99

1.6

1.5

15.13

14.73

pmol/l

0.16

164

Presence of other devices

314

1.51

1.99

1.7

1.4

13.84

15.29

pmol/l

1.32

258

Superficial injury of wrist and hand

352

1.48

1.98

1.5

1.6

13.50

14.36

pmol/l

0.89

300

Chronic rhinitis, nasopharyngitis and pharyngitis

518

1.39

1.98

1.7

1.4

13.62

14.89

pmol/l

1.52

436

Cutaneous abscess, furuncle and carbuncle

410

1.44

1.97

1.5

13.38

14.71

pmol/l

1.30

346

Functional dyspepsia

436

1.42

1.95

1.5

1.4

13.51

14.93

pmol/l

1.69

356

Inflammatory diseases of prostate (prostatitis)

1.94

1.2

1.5

16.07

18.33

pmol/l

0.49

Degenerative diseases of the nervous system

335

1.42

1.94

1.3

1.4

16.98

16.74

pmol/l

0.11

268

Other disorders of eyelid

668

1.33

1.93

1.4

1.5

14.40

15.82

pmol/l

2.06

550

Disorders resulting from impaired renal tubular function

2.74

1.93

1.3

1.8

13.24

15.23

pmol/l

—

COPD related to multimorbidity

417

1.40

1.93

1.3

1.5

15.91

16.38

pmol/l

0.26

340

Special screening examination for neoplasms

2.45

1.93

1.7

14.89

14.38

pmol/l

0.14

Primary coxarthrosis, bilateral

396

1.44

1.91

1.4

1.5

16.76

16.43

pmol/l

0.15

322

COPD, hospital admissions

495

1.36

1.91

1.2

1.4

15.78

16.07

pmol/l

0.17

408

Seronegative rheumatoid arthritis

158

1.71

1.88

1.2

1.6

15.03

15.79

pmol/l

0.27

133

Other abnormal uterine and vaginal bleeding

289

1.44

1.88

1.6

1.4

14.50

15.23

pmol/l

0.56

234

Myocardial infarction, without ST-elevation

426

1.40

1.87

1.4

17.62

16.12

pmol/l

0.33

345

Other complications of surgical and medical care, not elsewhere classified

136

1.77

1.87

1.6

1.5

14.35

14.44

pmol/l

0.02

118

Bruxism

2.88

1.86

1.6

1.3

11.75

13.23

pmol/l

—

Ankylosing spondylitis

107

1.87

1.86

1.3

1.6

15.33

15.17

pmol/l

0.04

Seropositive rheumatoid arthritis

372

1.45

1.85

1.2

1.5

15.84

15.67

pmol/l

0.08

303

Infective dermatitis

159

1.70

1.85

1.5

1.4

15.59

15.28

pmol/l

0.10

136

Skin changes due to chronic exposure to nonionizing radiation

490

1.37

1.84

1.4

15.48

16.38

pmol/l

0.80

398

Persons encountering health services in circumstances related to reproduction

130

687

1.27

1.83

1.5

14.59

14.88

pmol/l

0.25

114

593

Parkinson's disease

167

1.68

1.83

1.3

1.5

13.13

16.90

pmol/l

2.92

134

Alcohol abuse, main dg

206

1.60

1.82

1.2

1.5

13.75

15.32

pmol/l

0.55

176

Other disorders of patella

230

1.57

1.81

1.6

1.5

13.39

15.30

pmol/l

1.21

190

Leisure time condition

278

1.51

1.81

1.2

1.5

13.46

15.45

pmol/l

1.34

232

Other diseases of pancreas

101

1.89

1.80

1.8

1.6

14.83

15.41

pmol/l

0.26

Diabetic retinopathy, strict definition

268

1.49

1.79

1.5

1.4

15.34

14.57

pmol/l

0.53

229

Superficial injury of shoulder and upper arm

176

1.65

1.79

1.1

1.6

14.90

15.27

pmol/l

0.13

144

Parkinson's disease, including avohilmo

176

1.65

1.78

1.3

1.5

13.37

16.78

pmol/l

2.60

141

Assault

215

1.58

1.78

1.4

1.6

13.33

14.47

pmol/l

0.79

185

COPD, early/later onset

500

1.34

1.77

1.3

1.4

15.78

16.05

pmol/l

0.17

412

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

192

1.62

1.77

1.7

1.6

13.85

15.11

pmol/l

0.74

168

Undefined dementia

114

1.78

1.75

1.4

1.5

14.82

16.53

pmol/l

0.95

Disorders of conjunctiva

205

1326

1.20

1.74

1.5

1.4

14.73

14.57

pmol/l

0.21

176

1116

Simple and mucopurulent chronic bronchitis

2.51

1.74

1.3

1.5

13.63

15.39

pmol/l

—

Astigmatism

1.98

1.74

1.1

1.5

15.36

13.72

pmol/l

0.52

Artificial joint operation, meniscal resection

193

1023

1.21

1.73

1.4

1.5

15.36

15.07

pmol/l

0.32

163

852

Budesonide

217

1.57

1.73

1.5

14.19

14.22

pmol/l

0.01

177

Malignant neoplasm, wide definition

200

967

1.20

1.72

1.5

1.4

14.45

14.62

pmol/l

0.19

176

813

N06DA Anticholinesterases

343

1.39

1.72

1.3

1.4

16.72

16.95

pmol/l

0.12

272

Use of anticholinesterases

343

1.39

1.72

1.3

1.4

16.72

16.95

pmol/l

0.12

272

Wet age-related macular degeneration

194

1.59

1.71

1.7

1.4

18.56

16.80

pmol/l

1.00

148

Mixed and other personality disorders

125

1.76

1.71

1.5

11.69

15.31

pmol/l

2.47

106

Cerebral aneurysm, nonruptured

111

1.81

1.68

1.2

1.5

14.92

15.66

pmol/l

0.20

All influenza (not pneumonia)

203

1.58

1.67

1.3

1.6

14.16

14.47

pmol/l

0.18

169

ILD, hospital admission 2, with pulmonary infections

104

1.83

1.67

1.7

1.4

16.64

15.68

pmol/l

0.24

Malignant neoplasm, including Hilmo

199

966

1.20

1.67

1.5

1.4

14.46

14.60

pmol/l

0.16

175

812

Other disorders of amniotic fluid and membranes

258

1.50

1.66

1.4

1.3

13.16

13.21

pmol/l

0.03

219

Bacterial intestinal infections, IBD co-morbidities

276

1.49

1.65

1.3

1.5

16.14

15.60

pmol/l

0.08

228

Urticaria

545

1.34

1.65

1.5

14.91

14.80

pmol/l

0.02

456

Umbilical hernia

342

1.43

1.65

1.2

1.4

14.33

15.40

pmol/l

0.60

279

Excessive attrition of teeth

145

1170

1.23

1.64

1.4

14.74

14.33

pmol/l

0.20

116

997

Solid cancers, including Hilmo

194

942

1.20

1.63

1.5

1.4

14.55

14.61

pmol/l

0.06

172

793

Solid cancers

188

916

1.20

1.63

1.5

1.4

14.69

14.65

pmol/l

0.03

163

768

Pulmonary embolism

419

1.39

1.61

1.3

1.4

14.13

16.08

pmol/l

2.15

346

Tinnitus

352

1.42

1.61

1.7

1.4

14.82

15.72

pmol/l

0.48

294

Fall on same level involving ice and snow

133

1077

1.23

1.61

1.3

1.4

15.16

14.96

pmol/l

0.08

112

906

Superficial injury of lower leg

454

1.37

1.60

1.2

1.5

14.29

15.12

pmol/l

0.68

380

Caries of enamel

231

1284

1.18

1.60

1.5

1.4

13.88

14.78

pmol/l

1.61

196

1086

Other lesions of median nerve

2.51

1.60

1.1

1.8

14.63

15.49

pmol/l

—

Abnormal findings on diagnostic imaging of central nervous system

2.07

1.59

1.5

13.62

14.63

pmol/l

0.33

Other malignant neoplasms of skin (=non-melanoma skin cancer)

493

1.29

1.59

1.4

1.5

15.37

15.93

pmol/l

0.45

412

Dermatophytosis, including avohilmo

147

1180

1.22

1.59

1.4

14.23

14.86

pmol/l

0.82

125

993

Malignant neoplasm of skin, including Hilmo

111

587

1.27

1.59

1.4

15.68

15.47

pmol/l

0.16

491

Ulcerative colitis, NAS

206

1.56

1.59

1.2

1.6

14.47

14.82

pmol/l

0.13

174

Acute alcohol intoxication

320

1.44

1.58

1.2

1.5

14.11

15.38

pmol/l

0.60

270

Intracerebral haemorrhage

136

1.69

1.58

1.2

1.4

16.56

18.03

pmol/l

0.38

109

Pulmonary heart disease

421

1.38

1.58

1.3

1.4

14.13

16.08

pmol/l

2.15

347

Alzheimer disease

299

1.39

1.57

1.3

1.4

17.50

16.89

pmol/l

0.30

236

Personal history of other diseases and conditions

190

1.57

1.56

1.2

1.5

15.05

13.75

pmol/l

0.70

159

Trigger finger

199

1.56

1.4

1.5

14.72

15.35

pmol/l

0.25

170

Other surgical follow-up care

2.28

1.55

1.2

1.8

12.09

14.24

pmol/l

—

Abnormal serum enzyme levels

310

1.43

1.55

1.2

1.5

13.86

15.67

pmol/l

1.40

258

Nonsuppurative otitis media, including avohilmo

528

1.31

1.55

1.5

13.75

14.04

pmol/l

0.29

458

Embolic stroke

2.43

1.53

1.1

1.2

15.00

15.14

pmol/l

—

Coxarthrosis, primary, with hip surgery

633

1.29

1.53

1.3

1.5

16.41

16.00

pmol/l

0.28

523

Serous carcinoma of ovary, including Hilmo

0.00

1.52

0.0

1.5

—

15.73

—

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

0.00

1.52

0.0

1.3

—

15.58

—

Benign lipomatous neoplasm

450

1.36

1.52

1.5

14.59

15.56

pmol/l

0.73

376

Other diseases of biliary tract

108

1.76

1.50

1.2

1.6

12.60

15.25

pmol/l

1.46

Other noninflammatory disorders of uterus, except cervix

253

1.40

1.49

1.6

1.5

14.52

15.55

pmol/l

0.59

205

Postpartum care and examination

165

1.49

1.48

1.4

1.3

12.52

13.08

pmol/l

0.42

147

Other hammer toe(s) (acquired)

220

1.49

1.47

1.1

1.6

15.15

16.16

pmol/l

0.42

182

Malignant neoplasm of skin

105

564

1.26

1.47

1.4

15.45

15.59

pmol/l

0.09

471

Basal cell carcinoma

484

1.28

1.46

1.4

1.5

15.40

15.99

pmol/l

0.46

404

Other bursopathies

163

1.60

1.46

1.9

1.5

13.93

15.74

pmol/l

1.11

142

Basal cell carcinoma, including Hilmo

499

1.28

1.45

1.4

15.42

15.89

pmol/l

0.36

417

Malignant neoplasm

190

938

1.19

1.45

1.5

1.4

14.58

14.62

pmol/l

0.05

166

788

Benign neoplasm of breast

211

1.52

1.45

1.4

1.5

14.90

14.77

pmol/l

0.06

172

DVT of lower extremities and pulmonary embolism

625

1.29

1.45

1.3

1.4

15.07

15.81

pmol/l

0.66

514

Pregnancy hypertension

111

798

1.24

1.44

1.4

14.28

13.89

pmol/l

0.25

100

676

Polyuria

285

1.44

1.6

1.5

15.37

16.05

pmol/l

0.26

232

Hypertrophic cardiomyopathy

2.31

1.43

1.1

1.7

47.77

15.05

pmol/l

—

AV-block

146

1.58

1.42

1.1

1.5

16.38

14.78

pmol/l

0.94

114

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

123

870

1.23

1.41

1.4

14.22

13.96

pmol/l

0.17

111

730

ILD, hospital admissions 3, with pneumonia sepsis

1.82

1.41

1.8

1.4

16.77

16.03

pmol/l

—

Superficial injury of abdomen, lower back and pelvis

237

1.48

1.41

1.3

1.5

13.06

14.80

pmol/l

1.34

203

Ankylosing spondylitis, ICD10

118

1.70

1.41

1.3

1.5

15.33

15.36

pmol/l

0.01

103

COPD, hospital admissions 1, only main diagnosis

354

1.36

1.41

1.3

1.5

15.61

16.49

pmol/l

0.53

292

D07AA Corticosteroids, weak (group I)

245

1.47

1.40

1.6

1.5

13.98

14.44

pmol/l

0.26

204

Use of levodopa decarboxylase inhibitor

149

1.61

1.40

1.4

1.5

13.88

17.16

pmol/l

2.15

118

Unspecified haematuria

455

1.31

1.40

1.4

15.53

15.88

pmol/l

0.21

373

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

2.25

1.39

1.0

1.4

13.88

13.30

pmol/l

—

Melanocytic naevi of upper limb, including shoulder

2.42

1.39

1.4

1.5

15.46

13.85

pmol/l

—

Pedestrian injured in collision with car, pick-up truck or van

2.42

1.39

1.4

1.8

13.40

14.85

pmol/l

—

Malignant neoplasm

189

937

1.18

1.39

1.5

1.4

14.59

14.62

pmol/l

0.04

165

786

Cerebral palsy and other paralytic syndromes

150

1.60

1.37

1.2

1.5

14.10

15.29

pmol/l

0.46

127

Complications of other internal prosthetic devices, implants and grafts

2.20

1.37

1.2

1.5

14.78

14.30

pmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

104

1.73

1.36

1.8

15.13

14.90

pmol/l

0.06

Anti-inflammatory and antirheumatic products, non-steroids

210

1.37

1.36

1.5

13.74

15.00

pmol/l

1.13

183

Suppurative and unspecified otitis media

592

1.27

1.35

1.4

1.5

14.98

14.14

pmol/l

1.00

510

Other appendicitis

113

1.68

1.31

1.3

1.5

14.47

15.58

pmol/l

0.28

Gestational diabetes (for exclusion)

100

552

1.25

1.31

1.2

1.4

12.85

13.24

pmol/l

0.48

469

Rosacea

209

1.49

1.29

1.7

1.5

14.07

14.60

pmol/l

0.37

173

Congenital malformations of the nervous system

2.36

1.29

1.1

1.5

14.75

13.18

pmol/l

—

Benign neoplasm: Rectum, anus and anal canal

267

1.42

1.29

1.3

1.5

15.57

16.75

pmol/l

0.62

223

Postprocedural disorders of digestive system, not elsewhere classified

2.36

1.29

1.5

1.8

14.25

15.04

pmol/l

—

Benign paroxysmal vertigo

490

1.31

1.29

1.4

14.56

15.97

pmol/l

1.59

401

Carcinoma in situ of breast, intraductal

145

1.59

1.28

1.3

1.6

14.76

15.11

pmol/l

0.13

122

Left hemicolectomy

2.79

1.28

1.2

2.0

14.96

16.57

pmol/l

—

Unspecified jaundice

2.09

1.27

1.2

1.6

17.70

14.97

pmol/l

—

Primary open-angle glaucoma, strict

343

1.37

1.27

1.4

15.70

17.05

pmol/l

0.82

278

Artificial joint re-operation

1.79

1.27

1.2

1.7

16.70

15.88

pmol/l

—

Diabetic nephropathy

240

1.44

1.27

1.4

1.5

14.18

15.61

pmol/l

0.80

204

Diseases of male genital organs

257

1.31

1.26

1.5

14.48

16.29

pmol/l

1.18

227

Procreative management

498

1.27

1.25

1.7

1.4

14.37

14.39

pmol/l

0.02

435

Haemolytic anaemias

2.23

1.24

1.0

1.7

18.00

15.19

pmol/l

—

Other condition

236

1.44

1.24

1.4

1.6

13.66

14.74

pmol/l

0.59

202

Benign neoplasm: Rectum

236

1.44

1.24

1.4

1.5

15.77

16.54

pmol/l

0.33

197

Acute and subacute iridocyclitis

287

1.40

1.22

1.2

1.6

14.85

15.39

pmol/l

0.27

242

Propionic acid derivatives

210

1.34

1.22

1.6

1.5

13.91

15.00

pmol/l

0.86

183

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

1.97

1.22

1.5

1.4

12.63

15.54

pmol/l

0.72

Malignant neoplasm of tonsil and base of tongue, including Hilmo

2.64

1.21

1.2

1.4

13.64

14.90

pmol/l

—

Amputation of thigh

2.64

1.21

1.8

2.0

18.68

15.66

pmol/l

—

Polyarthritis, unspecified

2.17

1.21

1.8

1.6

12.99

13.31

pmol/l

—

Atopic dermatitis, strict definition

553

1.27

1.21

1.6

1.5

13.48

13.95

pmol/l

0.51

471

Other disorders of bone

305

1.38

1.20

1.3

1.6

13.21

15.21

pmol/l

1.71

255

Faecal incontinence

132

1.59

1.20

1.6

13.90

15.03

pmol/l

0.38

106

Iridocyclitis

357

1.35

1.19

1.2

1.5

14.72

15.64

pmol/l

0.59

297

Volvulus

2.31

1.19

1.3

1.7

15.33

14.81

pmol/l

—

Hypertrichosis

2.11

1.18

1.4

1.2

12.05

12.72

pmol/l

—

Vascular diseases of the intestine

2.11

1.18

1.0

1.6

15.88

14.53

pmol/l

—

FESS (DNB20)

189

1.48

1.18

1.6

1.5

14.21

14.92

pmol/l

0.34

163

Acne

188

1.48

1.18

1.3

1.5

13.60

14.00

pmol/l

0.18

159

Oter anti-inflammatory and antirheumatic agents, non-steroids

147

1.42

1.18

1.3

1.5

15.80

15.52

pmol/l

0.09

128

Parkinson's disease, strict definition

149

1.55

1.17

1.3

1.5

13.94

16.91

pmol/l

1.79

119

Conjunctivitis

185

1286

1.16

1.5

1.4

14.62

14.57

pmol/l

0.05

158

1084

Diabetic nephropathy, excluding more controls

201

1.42

1.16

1.4

14.18

14.69

pmol/l

0.21

169

Phlebitis and thrombophlebitis (not including DVT)

342

1.35

1.15

1.4

14.80

15.81

pmol/l

0.70

284

Communicating hydrocephalus

2.51

1.15

1.0

2.1

11.60

15.76

pmol/l

—

Ectropion of eyelid

0.00

1.15

0.0

1.7

—

14.92

—

Female genital prolapse

294

1.29

1.15

1.5

1.4

14.44

15.32

pmol/l

0.80

238

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

515

1.23

1.14

1.4

15.57

15.78

pmol/l

0.14

431

Glucosamine medication

597

1.23

1.13

1.4

1.5

15.77

16.13

pmol/l

0.28

491

Any death

121

706

1.20

1.13

1.2

1.5

17.02

15.34

pmol/l

0.82

100

586

Ethmoidectomy

191

1.47

1.13

1.6

1.5

14.21

14.91

pmol/l

0.33

165

Other inflammation of eyelid, including avohilmo

105

870

1.21

1.11

1.4

14.23

14.53

pmol/l

0.27

739

Primary open-angle glaucoma

406

1.30

1.11

1.3

1.4

15.79

16.69

pmol/l

0.55

335

Salpingitis and oophoritis

327

1.35

1.11

1.4

12.86

15.08

pmol/l

3.39

279

Hypertrophy of breast in women and men

353

1.33

1.11

1.4

1.5

13.26

14.44

pmol/l

0.99

295

Acute alcohol intoxication, ICD10

276

1.38

1.11

1.2

1.5

13.90

15.21

pmol/l

0.55

236

Early lumbar disc prolapse operation

184

1.47

1.10

1.5

14.09

14.25

pmol/l

0.06

158

Anterior Iridocyclitis

302

1.36

1.10

1.2

1.6

14.85

15.43

pmol/l

0.30

254

Endometriosis of ovary

284

1.36

1.10

1.3

1.4

14.19

14.87

pmol/l

0.41

233

Childhood allergy (age < 16)

213

1.39

1.10

1.4

13.89

13.18

pmol/l

0.49

184

Diabetic retinopathy, excluding more controls

303

1.28

1.10

1.6

1.4

15.99

14.38

pmol/l

1.04

254

Other melanin hyperpigmentation

2.39

1.09

1.4

1.7

15.44

15.07

pmol/l

—

Autoimmune hepatitis, wide definition

1.96

1.08

1.6

14.25

13.92

pmol/l

—

Unspecified urinary incontinence

128

1.57

1.08

1.1

1.7

16.33

14.94

pmol/l

0.59

102

Chronic laryngitis and laryngotracheitis

202

1.44

1.07

1.7

1.5

15.61

15.44

pmol/l

0.06

172

Lichen ruber planus, wide definition including periferal and oral lichen planus

365

1.32

1.06

1.5

14.95

15.87

pmol/l

0.63

310

Other/unspecified enthesopathies, not elsewhere classified

105

1.62

1.06

2.3

1.6

14.43

15.64

pmol/l

0.36

Hirsutism in women

2.13

1.05

1.1

1.2

11.91

12.56

pmol/l

—

Sequelae of other external causes

1.79

1.04

1.8

1.6

15.18

14.23

pmol/l

0.36

Restless leg syndrome

220

1.41

1.04

1.2

1.5

13.67

15.19

pmol/l

0.99

186

Problems related to lifestyle

162

1.48

1.04

1.4

1.5

12.35

14.86

pmol/l

1.65

136

Seropositive rheumatoid arthritis, wide

419

1.29

1.03

1.2

1.5

15.84

15.81

pmol/l

0.01

340

Acne, including avohilmo

345

1.29

1.03

1.3

1.4

13.38

13.58

pmol/l

0.12

293

Brain meningioma, including Hilmo

1.84

1.02

1.5

15.43

15.23

pmol/l

0.03

Female infertility

334

1.26

1.02

1.4

14.33

14.12

pmol/l

0.15

279

Sequelae of injuries of lower limb

130

1.54

1.02

1.2

1.5

12.40

15.25

pmol/l

1.93

116

Degeneration of macula and posterior pole

529

1.23

1.02

1.6

1.5

16.82

16.10

pmol/l

0.53

438

Other interstitial pulmonary diseases

171

1.46

1.02

1.6

1.4

15.79

16.17

pmol/l

0.10

135

Endometriosis of pelvic peritoneum

263

1.35

1.01

1.6

1.4

14.40

14.39

pmol/l

0.01

214

Diabetic retinopathy

408

1.23

1.01

1.5

1.4

16.02

14.71

pmol/l

0.98

344

Cystic kidney disease, including avohilmo

2.01

1.00

1.0

1.7

12.79

14.41

pmol/l

—

ILD, hospital admissions

172

1.46

0.99

1.6

1.4

15.79

16.97

pmol/l

0.32

137

Supervision of high-risk pregnancy

246

1.30

0.99

1.6

1.3

13.20

13.39

pmol/l

0.12

214

Inflammatory bowel disease

503

1.25

0.98

1.5

14.14

14.73

pmol/l

0.42

417

Lichen planus, including avohilmo

309

1.33

0.98

1.6

1.5

15.41

15.72

pmol/l

0.17

260

Invasive ventilation

1.67

0.97

1.0

1.5

16.22

14.39

pmol/l

—

Other benign neoplasms of skin

611

1.23

0.97

1.5

1.4

15.30

15.48

pmol/l

0.11

500

Other/unspecified rheumatoid arthritis

173

1.45

0.97

1.2

1.5

15.23

15.16

pmol/l

0.03

140

Interstitial lung disease

173

1.45

0.97

1.6

1.4

15.79

16.97

pmol/l

0.32

137

Interstitial lung disease endpoints

173

1.45

0.97

1.6

1.4

15.79

16.97

pmol/l

0.32

137

Chronic nephritic syndrome

1.95

0.97

2.3

1.7

18.00

14.81

pmol/l

—

Malignant neoplasm of rectum, including Hilmo

132

1.52

0.96

1.7

1.4

13.67

18.15

pmol/l

1.93

104

Benign neoplasm: Adrenal gland

100

1.60

0.96

1.4

1.6

16.45

14.95

pmol/l

0.60

Acute suppurative otitis media

445

1.26

0.95

1.5

15.27

13.87

pmol/l

1.92

385

Myocardial infarction, unclassifiable

200

1.39

0.95

1.3

1.4

17.10

16.66

pmol/l

0.09

156

Benign neoplasm: other/unspecified salivary gland

2.23

0.93

1.0

1.7

18.67

16.23

pmol/l

—

Long labour

424

0.76

0.92

1.2

1.4

13.77

13.25

pmol/l

0.25

357

Noninflammatory disorders of female genital tract

415

1.20

0.92

1.5

1.4

14.43

14.46

pmol/l

0.02

348

Benign neoplasm: Pancreas

2.15

0.91

1.2

1.6

15.83

14.92

pmol/l

—

Carcinoma in situ of other and unspecified sites

2.15

0.91

2.0

1.6

15.52

15.26

pmol/l

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

111

551

1.18

0.91

1.4

13.31

13.76

pmol/l

0.53

463

Other noninflammatory disorders of vagina

134

1.50

0.91

1.3

1.4

12.28

15.01

pmol/l

2.57

108

Childhood asthma (age<16)

156

1.40

0.91

1.4

13.84

13.09

pmol/l

0.44

136

Childhood asthma (age<16), excluding more controls

156

1.40

0.91

1.4

13.84

13.01

pmol/l

0.51

136

Hypertrophy of breast

331

1.30

0.90

1.4

1.5

13.07

14.14

pmol/l

0.98

274

Demyelinating diseases of the central nervous system

143

1.47

0.89

1.4

1.5

14.16

14.64

pmol/l

0.17

121

Labour and delivery complicated by fetal stress [distress]

341

1.24

0.89

1.4

12.75

13.02

pmol/l

0.22

295

Spirochaetal infections, other/unspecified, including avohilmo

574

0.78

0.88

1.4

14.71

15.34

pmol/l

0.42

474

Lichen sclerosus et atrophicus

177

1.41

0.88

1.5

1.4

14.24

14.82

pmol/l

0.23

147

Malignant neoplasm of pancreas, including Hilmo

1.61

0.87

1.3

1.4

15.01

17.62

pmol/l

0.70

Monoarthritis, not elsewhere classified

1.86

0.87

1.1

1.9

14.31

13.63

pmol/l

—

Otitis externa, unspecified

169

1.42

0.87

2.0

1.5

14.35

14.95

pmol/l

0.28

148

Pre-eclampsia or eclampsia

404

1.26

0.87

1.5

1.4

13.87

13.93

pmol/l

0.04

336

Hydronephrosis

144

1.46

0.87

1.4

1.6

14.00

14.77

pmol/l

0.35

118

Embedded and impacted teeth

429

1.23

0.86

1.7

1.4

13.61

13.73

pmol/l

0.08

367

Other spirochaetal diseases, including avohilmo

583

0.79

0.86

1.4

14.59

15.38

pmol/l

0.57

483

Fracture at wrist and hand level

556

1.22

0.85

1.4

1.5

14.24

14.94

pmol/l

0.61

466

Lyme disease

571

0.79

0.85

1.4

14.71

15.30

pmol/l

0.39

471

Lyme disease, including avohilmo

571

0.79

0.85

1.4

14.71

15.30

pmol/l

0.39

471

Other enthesopathy of foot (+metatarsalgia)

145

1.45

0.84

1.1

1.5

13.83

15.36

pmol/l

0.69

126

Cystic kidney disease

1.94

0.84

1.0

1.8

13.45

14.40

pmol/l

—

Sixth [abducent] nerve palsy

1.94

0.84

1.0

1.5

14.83

14.47

pmol/l

—

Allergic contact dermatitis

230

1.35

0.84

1.7

1.4

13.63

14.98

pmol/l

0.77

193

Rheumatoid arthritis, including avohilmo

641

1.20

0.84

1.2

1.4

15.35

15.41

pmol/l

0.04

529

Other aneurysm

1.78

0.84

1.4

1.5

13.88

15.21

pmol/l

—

Carcinoma in situ of skin of other and unspecified parts of face

1.59

0.84

1.6

17.71

16.05

pmol/l

—

Allergic rhinitis

570

1.21

0.84

1.4

1.5

13.68

14.13

pmol/l

0.43

484

Brain meningioma

1.76

0.83

1.5

15.37

15.20

pmol/l

—

Chronic tubulo-interstitial nephritis

1.74

0.82

1.3

1.7

16.30

14.34

pmol/l

—

malignant neoplasm of female genital organs

267

0.70

0.82

1.5

1.4

14.06

15.87

pmol/l

1.25

220

malignant neoplasm of female genital organs, including Hilmo

293

0.71

0.82

1.5

14.42

15.81

pmol/l

0.97

242

Hallux rigidus

172

1.40

0.80

1.5

1.6

16.35

16.84

pmol/l

0.12

145

severe traumatic brain injury, does not include concussion

276

1.31

0.80

1.2

1.5

14.41

16.22

pmol/l

1.04

225

Malignant neoplasm of liver and intrahepatic bile ducts

0.00

0.79

0.0

1.4

—

15.61

—

Other and unspecified mononeuropathies of upper limb

1.82

0.79

1.5

1.6

14.07

14.73

pmol/l

—

Small cell lung cancer, helper endpoint

0.00

0.79

0.0

1.8

—

15.51

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

446

1.23

0.79

1.2

1.5

13.69

15.39

pmol/l

1.70

369

Other spirochaetal diseases

575

0.80

0.79

1.4

14.59

15.33

pmol/l

0.53

475

Hidradenitis suppurativa

1.67

0.78

2.3

1.4

12.18

13.34

pmol/l

—

Infections with a predominantly sexual mode of transmission

604

0.81

0.76

1.3

1.5

13.49

13.88

pmol/l

0.30

506

Malignant neoplasm of breast, HER-positive

495

1.19

0.76

1.5

14.52

14.91

pmol/l

0.38

417

Malignant neoplasm of breast, ER-positive, including Hilmo

495

1.19

0.75

1.5

14.52

14.91

pmol/l

0.38

417

Toxic effects of substances chiefly nonmedicinal as to source

166

1.39

0.75

1.5

1.6

12.71

14.85

pmol/l

1.20

142

Pre-eclampsia or poor fetal growth

620

1.19

0.74

1.5

1.4

13.54

13.69

pmol/l

0.13

527

Erythema intertrigo

2.09

0.74

2.4

1.3

17.20

15.57

pmol/l

—

Arterial embolism and thrombosis of lower extremity artery

2.09

0.74

1.0

1.6

38.20

15.96

pmol/l

—

Other hearing loss

375

1.24

0.73

1.4

15.36

16.26

pmol/l

0.43

313

Congenital malformations of ovaries, fallopian tubes and broad ligaments

100

1.50

0.72

1.7

1.4

13.85

13.65

pmol/l

0.07

Acquired haemolytic anaemia

2.01

0.72

1.0

1.9

16.40

15.74

pmol/l

—

Assault by bodily force

125

1.44

0.72

1.6

13.54

14.83

pmol/l

0.51

107

Other dialysis

1.93

0.70

1.2

1.9

15.36

14.82

pmol/l

—

Bronchiectasis

1.53

0.69

2.1

1.6

14.10

15.56

pmol/l

—

Endometriosis ASRM stages 1,2

328

1.25

0.68

1.6

1.4

14.10

13.91

pmol/l

0.10

269

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.86

0.68

2.2

1.2

15.00

14.90

pmol/l

—

Dysplasia of cervi uteri

312

1.22

0.68

1.2

1.4

13.85

14.18

pmol/l

0.22

255

All dysplastic lesions of the cervix uteri, vagina or vulva

596

1.18

0.68

1.3

1.4

13.68

13.48

pmol/l

0.16

499

Fibroblastic disorders

284

1.27

0.67

1.4

14.69

15.62

pmol/l

0.47

240

Prolonged pregnancy

272

0.75

0.67

1.2

1.3

11.24

13.04

pmol/l

2.70

235

Fracture of skull and facial bones

320

1.25

0.67

1.4

1.6

13.67

14.84

pmol/l

0.86

269

Primary_lymphoid and hematopoietic malignant neoplasms

320

1.25

0.67

1.5

16.26

16.15

pmol/l

0.03

265

Uterine polyps

307

1.20

0.67

1.4

13.89

15.25

pmol/l

1.63

250

Other (seronegative) rheumatoid arthritis, wide

294

1.26

0.66

1.2

1.5

15.33

16.14

pmol/l

0.40

241

Injury of muscle and tendon at shoulder and upper arm level

466

1.20

0.66

1.8

1.4

14.29

15.69

pmol/l

1.36

389

Other and unspecified disorders of vitreous body

699

1.16

0.66

1.3

1.5

14.94

15.58

pmol/l

0.59

586

DVT of lower extremities

259

1.28

0.65

1.4

16.47

16.28

pmol/l

0.06

218

Keratitis

596

1.18

0.64

1.3

1.4

14.04

15.11

pmol/l

0.95

495

Adenocarcinoma and papilloma adenocarcinoma of rectum

103

1.46

0.64

1.8

1.4

13.21

17.09

pmol/l

—

Periodontal disease, other/unspecified

1.73

0.64

2.2

1.2

14.96

14.31

pmol/l

—

Vascular dementia (subcortical)

1.73

0.64

1.0

1.8

15.24

16.19

pmol/l

—

L02BG Aromatase inhibitors

590

1.17

0.63

1.5

14.46

15.35

pmol/l

1.12

489

Left ventricular outflow tract obstruction (LVOTO), broad definition

121

1.41

0.62

1.3

1.6

13.98

15.07

pmol/l

0.36

107

Malignant neoplasm of pancreas

1.55

0.62

1.2

1.4

15.10

15.68

pmol/l

0.15

Viral pneumonia (known virus, not influenza)

1.67

0.61

1.2

1.9

15.84

15.28

pmol/l

—

Other diseases of gallbladder

1.60

0.61

1.4

1.8

14.55

15.29

pmol/l

—

ILD, hospital admissions 1, main diag only

156

1.35

0.60

1.1

1.5

15.67

17.46

pmol/l

0.44

125

Other/unspecified seropositive rheumatoid arthritis

416

1.20

0.60

1.2

1.5

15.90

15.82

pmol/l

0.03

337

Small cell lung cancer, including Hilmo

0.00

0.59

0.0

1.1

—

15.89

—

Small cell lung cancer

0.00

0.59

0.0

1.1

—

15.89

—

Appendicitis, broad definition

154

1249

1.11

0.59

1.4

14.02

14.64

pmol/l

0.66

135

1049

Inguinal hernia

547

1.14

0.59

1.5

1.4

14.85

15.70

pmol/l

0.74

457

Ulcerative colitis

381

1.21

0.59

1.2

1.5

13.99

14.97

pmol/l

0.61

321

Colorectal cancer, including Hilmo

355

1.21

0.58

1.7

1.4

14.24

16.44

pmol/l

2.19

294

Artificial opening status

1.51

0.58

1.3

1.5

13.36

14.37

pmol/l

—

Benign neoplasm: Other and unspecified parts of mouth

1.72

0.57

2.0

1.5

19.17

14.96

pmol/l

—

Other blood glucose lowering drugs, excl. Insulins

184

1.31

0.57

1.4

15.04

17.51

pmol/l

0.96

149

Diseases of appendix

155

1256

1.10

0.57

1.4

14.00

14.65

pmol/l

0.71

136

1053

Liquid cancers, including Hilmo

475

1.17

0.56

1.5

1.4

16.17

15.96

pmol/l

0.08

391

Endometriosis ASRM stages 3,4

429

1.19

0.56

1.5

1.4

14.35

14.57

pmol/l

0.11

345

Dislocation, sprain and strain of joints and ligaments of knee

130

1057

1.11

0.56

1.4

14.34

14.53

pmol/l

0.17

115

893

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

124

1.37

0.55

1.9

1.5

13.74

15.29

pmol/l

0.58

107

Panniculitis affecting regions of neck and back

1.62

0.55

1.2

1.7

13.17

13.73

pmol/l

—

Blepharochalasis

439

1.19

0.55

1.3

1.5

14.34

16.11

pmol/l

1.98

362

Maternal care for cervical incompetence

1.50

0.54

1.7

1.2

15.13

14.08

pmol/l

—

Burns and corrosions

204

1.28

0.54

1.3

1.5

13.66

14.57

pmol/l

0.42

174

Other specified and unspecified disorders of eye and adnexa

1.54

0.53

1.2

1.7

15.67

14.97

pmol/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

108

1.39

0.53

1.8

1.4

13.21

17.15

pmol/l

—

Liquid cancers

400

1.18

0.53

1.5

1.4

16.75

16.24

pmol/l

0.16

333

Alzheimer’s disease, strict definition

252

1.22

0.52

1.3

1.4

17.01

16.63

pmol/l

0.17

194

Other menopausal disorders

281

1.17

0.51

1.7

1.4

14.90

15.11

pmol/l

0.13

232

Medical abortion

163

805

1.10

0.51

1.6

1.4

13.71

14.55

pmol/l

1.89

134

668

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

126

1.35

0.51

1.2

1.5

12.21

13.44

pmol/l

0.57

107

Metatarsalgia

135

1.33

0.51

1.2

1.6

14.23

15.43

pmol/l

0.45

118

Anogenital herpesviral [herpes simplex] infection

110

0.64

0.48

1.1

1.5

13.64

13.66

pmol/l

—

Pre-eclampsia

372

1.18

0.48

1.5

1.4

13.56

13.88

pmol/l

0.22

308

Obstructed labour due to malposition and malpresentation of fetus

430

0.84

0.48

1.1

1.4

13.30

13.33

pmol/l

0.02

366

Other infective otitis externa

1.45

0.48

2.0

1.5

13.82

13.88

pmol/l

0.03

Malignant neoplasm of breast

571

1.12

0.48

1.4

15.04

14.67

pmol/l

0.34

477

Prolapse and hernia of ovary and fallopian tube

1.51

0.48

1.4

1.5

15.69

16.45

pmol/l

—

Golimumab

1.49

0.47

1.0

1.7

13.71

14.20

pmol/l

—

Follicular cysts of skin and subcutaneous tissue

272

1.21

0.47

1.3

1.4

18.79

15.50

pmol/l

0.45

232

Primary angle-closure glaucoma

1.43

0.46

1.0

1.9

15.11

15.41

pmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

129

1.32

0.45

1.2

1.4

12.21

13.39

pmol/l

0.54

108

Ulcerative proctitis

0.59

0.45

1.4

1.6

12.10

15.19

pmol/l

—

Arterial embolism and thrombosis

1.40

0.45

1.0

1.4

33.14

15.06

pmol/l

—

Melanocytic naevi of other and unspecified parts of face

1.40

0.44

1.4

1.6

12.39

14.19

pmol/l

0.78

Bilateral sagittal split ramus osteotomy operation

1.37

0.44

1.7

1.5

13.03

13.48

pmol/l

—

Fitting and adjustment of other devices

462

1.14

0.44

1.5

14.15

15.95

pmol/l

2.60

369

Medicines for HER+ breast cancer

700

1.12

0.44

1.5

14.47

15.18

pmol/l

0.94

584

Coagulation defects, purpura and other haemorrhagic conditions

293

1.20

0.43

1.1

1.5

14.68

15.38

pmol/l

0.35

239

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

414

1.16

0.43

1.2

1.5

15.82

15.85

pmol/l

0.01

335

Pollen allergy

344

1.18

0.43

1.2

1.5

13.73

14.28

pmol/l

0.36

291

Other specified/unspecified systemic involvement of connective tissue

1.41

0.43

1.5

15.18

14.50

pmol/l

0.25

Benign neoplasm: Vulva

1.62

0.43

1.4

14.88

14.47

pmol/l

—

Peripheral retinal degeneration

1.62

0.43

2.2

1.6

17.40

14.60

pmol/l

—

Polycythaemia vera

1.62

0.43

1.6

1.3

14.54

14.69

pmol/l

—

Right bundle-branch block

1.61

0.43

1.0

1.6

22.80

14.17

pmol/l

—

Corneal ulcer

303

1.19

0.43

1.2

1.6

14.09

15.23

pmol/l

0.62

256

Pediculosis, acariasis and other infestations, including avohilmo

303

1.19

0.42

1.3

1.5

14.19

14.38

pmol/l

0.09

259

L01XE Protein kinase inhibitors

1.43

0.42

2.5

1.7

18.13

15.43

pmol/l

—

Other osteochondropathies

0.66

0.42

1.2

1.5

13.35

15.40

pmol/l

—

Herpesviral [herpes simplex] infections, including avohilmo

462

1.15

0.42

1.3

1.4

12.39

14.39

pmol/l

2.46

381

Certain zoonotic bacterial diseases, including avohilmo

1.52

0.41

2.2

1.8

14.60

14.37

pmol/l

—

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

0.00

0.41

0.0

1.1

—

15.53

—

Hepatocellular carcinoma

0.00

0.41

0.0

1.1

—

16.22

—

Other abnormal findings in urine

0.00

0.41

0.0

1.3

—

16.07

—

LeFortI or BSSO operation

1.36

0.41

1.6

1.5

13.03

13.75

pmol/l

—

Residual foreign body in soft tissue

1.36

0.41

1.4

1.7

13.44

13.72

pmol/l

—

Other inflammatory liver diseases

1.39

0.40

1.5

14.18

15.86

pmol/l

0.46

Superficial injury of hip and thigh

213

1.22

0.40

1.5

1.4

17.66

15.46

pmol/l

0.32

168

Suppurative otitis media, unspecified

1.47

0.40

1.6

1.8

15.60

14.58

pmol/l

—

Respiratory disorders in diseases classified elsewhere

0.00

0.40

0.0

2.2

—

16.65

—

Chondropathies

241

1.20

0.40

1.2

1.6

13.63

14.76

pmol/l

0.59

204

Hydrocele

1.36

0.40

1.3

1.5

15.42

18.36

pmol/l

0.60

Congenital malformations of breast, including avohilmo

1.43

0.39

1.8

1.1

12.00

12.85

pmol/l

—

Acute appendicitis

140

1201

1.08

0.39

1.4

13.90

14.65

pmol/l

0.84

121

1008

Hepatocellular carcinoma, including Hilmo

0.00

0.39

0.0

1.1

—

16.62

—

Malignant neoplasm of rectum

106

1.32

0.39

1.5

1.4

12.44

17.10

pmol/l

—

Postmenopausal atrophic vaginitis

259

0.86

0.38

1.6

1.4

14.51

15.61

pmol/l

0.92

213

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

127

1123

1.08

0.37

1.4

14.62

14.47

pmol/l

0.14

107

952

Spontaneous abortion

113

694

1.09

0.37

1.5

1.4

13.27

14.35

pmol/l

1.84

581

Other facial nerve disorders

1.35

0.37

1.2

1.6

14.20

14.55

pmol/l

—

Need for other prophylactic measures

1.31

0.37

1.0

1.5

11.94

14.41

pmol/l

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

1.35

0.37

1.2

1.7

12.26

14.96

pmol/l

—

Non-small cell lung cancer, squamous, helper endpoint

1.35

0.37

3.2

1.3

13.18

15.53

pmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

152

1.25

0.37

1.3

1.4

12.45

13.86

pmol/l

0.77

125

Additional codes for the location of defect, injury or illness

1.39

0.37

1.4

1.5

12.90

14.51

pmol/l

—

Malignant neoplasm of breast, HER2-negative

571

1.10

0.36

1.4

14.95

14.67

pmol/l

0.24

477

Inguinal hernia, bilateral

0.63

0.35

1.4

1.5

12.72

18.03

pmol/l

—

Malignant neoplasm of breast, including Hilmo

580

1.09

0.35

1.5

1.4

15.23

14.66

pmol/l

0.59

485

Maternal care for known or suspected abnormality of pelvic organs

348

1.13

0.35

1.7

1.3

12.85

13.19

pmol/l

0.21

293

!Aliquae complicationes praecoces traumatis

1.40

0.35

1.2

1.7

15.55

14.31

pmol/l

—

Early complications of trauma

1.40

0.35

1.2

1.7

15.55

14.31

pmol/l

—

Other and unspecified effects of external causes

480

1.13

0.34

1.4

1.5

14.29

14.57

pmol/l

0.16

404

Calculus of lower urinary tract

1.36

0.34

1.3

1.5

14.60

14.24

pmol/l

—

Antenatal screening

257

0.87

0.34

1.5

1.3

13.14

13.47

pmol/l

0.21

224

Use of rivastigmine

190

1.21

0.34

1.3

1.4

16.16

16.31

pmol/l

0.06

141

Multiple myeloma, including Hilmo

1.33

0.33

1.5

1.4

13.48

15.19

pmol/l

—

Maternal care for known or suspected malpresentation of fetus

268

1.14

0.33

1.8

1.3

12.30

13.07

pmol/l

0.80

233

Idiopathic gout

1.32

0.33

1.3

1.5

16.24

18.00

pmol/l

0.32

Conjunctivitis (acute, non atopic)

479

1.12

0.33

1.6

1.4

14.36

14.87

pmol/l

0.34

393

Pruritus

182

1.21

0.33

1.3

1.4

13.80

15.27

pmol/l

0.71

152

Melanoma in situ

1.28

0.32

1.2

1.7

15.17

14.73

pmol/l

—

Congenital ovarian cysts

1.33

0.32

1.9

1.5

13.34

13.50

pmol/l

0.05

Acute appendicitis, no complications

108

996

1.08

0.31

1.4

13.51

14.58

pmol/l

1.78

852

Ulcer of vagina/vulva

1.32

0.31

1.4

15.90

13.96

pmol/l

—

Other disorders of pigmentation

1.32

0.30

1.4

1.6

17.17

14.49

pmol/l

—

Haemorrhage in early pregnancy

526

1.11

0.30

1.3

1.4

14.12

13.99

pmol/l

0.09

448

Covid-19 suspected case

379

0.87

0.30

2.0

1.5

14.49

14.42

pmol/l

0.03

322

Seborrhoeic keratosis

371

1.13

0.30

1.4

15.80

16.03

pmol/l

0.11

304

Single spontaneous delivery

456

0.91

0.30

1.4

15.00

14.59

pmol/l

0.33

365

Distal bite

1.26

0.29

2.0

1.6

13.00

13.57

pmol/l

—

Chalazion

166

1.21

0.29

1.6

1.5

14.49

15.21

pmol/l

0.23

140

Alzheimer’s disease (Late onset)

236

1.15

0.29

1.4

17.47

16.80

pmol/l

0.30

181

Complications of labour and delivery

136

805

0.94

0.29

1.4

13.91

14.37

pmol/l

0.56

114

674

Complications predominantly related to the puerperium

513

0.90

0.28

1.3

1.4

13.09

13.97

pmol/l

0.93

433

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

158

1.20

0.28

1.3

1.5

12.45

13.92

pmol/l

0.81

127

Calculus of kidney and ureter

393

1.12

0.28

1.3

1.5

13.03

15.61

pmol/l

2.41

328

Other diseases of liver

280

1.14

0.27

1.3

1.6

13.73

15.60

pmol/l

1.31

240

Adverse effects, not elsewhere classified

337

1.13

0.27

1.5

14.70

14.67

pmol/l

0.01

288

Tuberculosis, wide, including avohilmo

0.70

0.26

1.0

1.6

10.02

15.23

pmol/l

—

Family history of certain disabilities and chronic diseases leading to disablement

0.68

0.26

1.6

17.82

13.77

pmol/l

—

Unspecified lump in breast

291

1.13

0.26

1.3

1.5

14.17

15.03

pmol/l

0.50

237

Malignant neoplasm of digestive organs, including Hilmo

473

1.09

0.26

1.5

14.62

15.94

pmol/l

1.34

393

Postmenopausal bleeding

251

1.11

0.25

1.7

1.5

15.46

15.72

pmol/l

0.13

206

Use of donepezil

242

1.14

0.25

1.4

17.22

16.52

pmol/l

0.30

187

Effects of foreign body entering through natural orifice

351

0.88

0.25

1.1

1.5

13.86

15.04

pmol/l

0.58

296

Malignant neoplasm of breast, HER2-negative, including Hilmo

580

1.07

0.25

1.5

1.4

15.14

14.66

pmol/l

0.47

485

Allergic conjunctivitis

131

1191

1.06

0.24

1.4

1.5

14.66

14.48

pmol/l

0.18

111

1011

Urolithiasis

417

1.10

0.24

1.3

1.4

12.82

15.63

pmol/l

2.94

347

Radial styloid tenosynovitis [de Quervain]

0.71

0.24

1.2

1.5

14.75

14.48

pmol/l

—

Follicular lymphoma, hilmo

1.32

0.23

1.4

1.6

17.00

15.44

pmol/l

—

Other disorders of veins

715

1.07

0.23

1.4

15.29

15.15

pmol/l

0.08

604

Non-small cell lung cancer, squamous

1.28

0.23

3.2

1.2

13.18

16.17

pmol/l

—

Presbycusis

160

1.17

0.22

1.4

18.82

16.56

pmol/l

0.54

125

Benign neoplasm: Rectosigmoid junction

1.25

0.22

2.8

1.5

16.00

14.21

pmol/l

—

Scabies, including avohilmo

257

1.13

0.22

1.4

1.5

14.08

14.42

pmol/l

0.17

216

Premature rupture of membranes

319

1.09

0.21

1.3

13.70

13.20

pmol/l

0.39

272

Pregnancy, childbirth and the puerperium

309

1.08

0.21

1.4

14.66

14.82

pmol/l

0.11

244

Medial epicondylitis

1.25

0.20

1.0

1.5

10.97

16.03

pmol/l

—

Benign leiomyoma with endometriosis

278

1.12

0.20

1.3

1.5

17.19

15.40

pmol/l

0.99

229

Viral warts, including avohilmo

376

0.90

0.20

1.6

1.5

14.15

15.03

pmol/l

0.48

317

Impacted maxillary molar

112

0.80

0.20

1.3

12.51

13.26

pmol/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

490

1.08

0.19

1.5

13.19

14.32

pmol/l

1.18

415

Other fall from one level to another

346

1.10

0.19

1.2

1.4

13.90

15.04

pmol/l

0.70

288

Malignant neoplasm of breast, HER-negative

351

1.09

0.19

1.4

1.5

16.80

15.55

pmol/l

0.79

293

Other juvenile arthritis

1.13

0.18

1.3

1.4

14.73

13.07

pmol/l

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

290

0.90

0.18

1.2

1.6

14.21

14.67

pmol/l

0.21

244

Tuberculosis, IBD comorbidity

0.71

0.16

1.0

1.7

10.02

15.12

pmol/l

—

Tuberculosis, wide

0.71

0.16

1.0

1.7

10.02

15.21

pmol/l

—

Delivery, wide proxy

375

1.06

0.16

1.3

1.4

14.22

14.62

pmol/l

0.33

301

Colorectal cancer

317

1.09

0.16

1.5

1.4

13.92

16.69

pmol/l

2.37

258

Supervision of normal pregnancy

253

0.92

0.16

1.5

1.3

12.09

13.42

pmol/l

1.76

221

5-aminosalicylic acid

323

1.08

0.14

1.2

1.5

14.66

13.94

pmol/l

0.49

267

Secondary and unspecified malignant neoplasm of lymph nodes

0.82

0.13

2.3

1.4

14.92

17.65

pmol/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

109

834

0.96

0.13

1.2

1.4

13.11

14.06

pmol/l

1.90

702

Other disorders of the genitourinary system

199

1.11

0.13

1.5

1.6

13.66

15.56

pmol/l

0.97

166

Carcinoma in situ of skin

1.17

0.13

1.7

1.6

16.17

15.62

pmol/l

—

Leiomyoma of uterus

146

792

1.03

0.13

1.4

15.04

14.46

pmol/l

0.77

118

658

Malignant neoplasm of breast, ER-negative, including Hilmo

377

1.07

0.12

1.5

16.91

15.47

pmol/l

1.03

312

Rash and other nonspecific skin eruption

144

1.11

0.10

2.2

1.7

15.20

14.65

pmol/l

—

122

Injury of eye and orbit

208

0.91

0.10

1.2

1.6

12.69

14.73

pmol/l

1.15

178

Otosclerosis

1.15

0.10

1.0

1.7

16.30

16.23

pmol/l

0.01

Disturbances of smell and taste

1.06

0.09

1.0

1.6

14.40

13.96

pmol/l

—

Dislocation, sprain and strain of joints and ligaments of elbow

1.15

0.09

1.0

1.5

16.01

15.94

pmol/l

—

Other superficial mycoses, including avohilmo

174

1.09

0.09

1.7

1.5

14.06

14.53

pmol/l

0.10

144

Perineal laceration during delivery

298

1.06

0.09

1.5

1.4

12.14

13.26

pmol/l

1.32

254

Contusion of ankle

0.83

0.08

1.0

1.5

11.78

13.92

pmol/l

—

Malignant neoplasm of digestive organs

435

1.04

0.07

1.4

14.48

16.12

pmol/l

1.57

359

IBD patients in KELA-register

363

1.05

0.07

1.4

1.5

14.55

14.86

pmol/l

0.16

309

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

1.06

0.07

1.1

1.3

15.11

14.32

pmol/l

—

All dysplastic lesions of the cervix uteri

532

1.04

0.07

1.2

1.4

13.62

13.36

pmol/l

0.19

440

Eustachian salpingitis and obstruction

128

1.09

0.06

1.4

1.5

12.94

14.73

pmol/l

0.88

109

Pregnancy with abortive outcome

154

817

0.98

0.06

1.5

1.4

13.86

14.59

pmol/l

1.37

129

677

Other obstetric trauma

102

0.88

0.06

1.2

1.4

11.57

13.45

pmol/l

—

Divergent concomitant strabismus

109

1.10

0.06

2.2

1.5

14.83

15.04

pmol/l

0.07

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

124

944

1.02

0.06

1.2

1.4

14.04

14.47

pmol/l

0.33

104

798

Infections with a predominantly sexual mode of transmission, including avohilmo

753

1.02

0.04

1.5

1.4

13.26

13.84

pmol/l

0.69

644

Puerperal sepsis

231

0.95

0.04

1.3

1.4

12.52

14.78

pmol/l

1.72

194

Polyp of the female genital tract

321

1.02

0.03

1.5

1.4

14.13

15.09

pmol/l

0.94

261

Obstructed labour due to maternal pelvic abnormality

269

0.97

0.02

1.4

14.67

14.07

pmol/l

0.32

229

L02BA Anti-estrogens

298

0.97

0.02

1.6

1.5

14.60

15.24

pmol/l

0.36

247

Delivery

458

0.99

0.01

1.5

1.4

14.64

14.58

pmol/l

0.04

367

Other disorders of cornea

136

0.96

0.00

1.2

1.6

15.88

15.40

pmol/l

—

118

Inflammatory bowel disease, strict (require KELA)

386

0.98

0.00

1.4

1.5

14.55

14.86

pmol/l

0.16

329

Sulfonylureas

313

1.01

0.00

1.5

1.4

14.94

17.14

pmol/l

1.29

253

Postpartum haemorrhage

450

0.99

0.00

1.4

12.85

13.26

pmol/l

0.35

384

Appendectomy

127

1210

1.00

0.00

1.4

13.09

14.74

pmol/l

4.77

114

1018

Postpartum hemorraghe, parous women as controls

448

1.01

0.00

1.4

12.85

13.21

pmol/l

0.30

381

Other complications of labour and delivery, not elsewhere classified

214

0.99

0.00

1.2

1.3

12.92

13.00

pmol/l

0.04

179

Bitten or struck by other mammals

193

0.98

0.00

1.3

1.5

13.49

14.56

pmol/l

0.43

164

Colorectal adenocarcinoma

244

1.01

0.00

1.6

1.4

14.51

16.94

pmol/l

1.37

196

Exposure to other and unspecified inanimate mechanical forces

1.04

0.00

1.2

1.4

13.84

14.76

pmol/l

—

Postpartum hemorraghe, all women as controls

528

1.00

0.00

1.4

12.85

13.16

pmol/l

0.25

445

Fetus and newborn affected by maternal complications of pregnancy

0.00

0.0

1.6

—

14.86

—

Other injuries of spine and trunk, level unspecified

0.00

0.0

1.0

—

14.30

—

Cholesteatoma of middle ear

0.94

0.00

2.0

1.7

16.42

14.55

pmol/l

—

Reiter disease

0.00

0.0

2.8

—

18.68

—

Cleft lip and cleft lip and palate

0.00

0.0

1.8

—

12.30

—

Cholesteatoma of external ear

0.00

0.0

1.2

—

17.40

—

Acute myringitis

0.00

0.0

1.0

—

13.57

—

Other congenital malformations of heart

0.00

-0.00

0.0

1.2

—

14.33

—

Senility

0.00

-0.00

0.0

1.8

—

14.83

—

Tuberculosis

0.89

-0.00

1.0

1.7

12.02

15.09

pmol/l

—

Seminoma of testis

0.00

-0.00

0.0

1.5

—

16.88

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

0.92

-0.00

1.2

1.5

15.67

pmol/l

—

Other specified/unspecified bacterial intestinal infections

1.00

-0.00

1.0

1.7

13.88

14.69

pmol/l

—

Juvenile arthritis (FINNGEN)

0.87

-0.00

1.3

14.73

13.19

pmol/l

—

Female pelvic inflammatory disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.8

—

12.14

—

Seminoma of testis, including Hilmo

0.00

-0.00

0.0

1.5

—

16.88

—

Maxillary prognathism

0.00

-0.00

0.0

1.4

—

15.20

—

Other congenital malformations of kidney

0.00

-0.00

0.0

1.2

—

16.20

—

Exposure to unspecified smoke, fire and flames

0.00

-0.00

0.0

1.1

—

17.03

—

Birth trauma

0.00

-0.00

0.0

1.7

—

14.42

—

Infections of breast associated with childbirth

0.88

-0.00

1.2

13.95

13.21

pmol/l

—

Other and unspecified vaccines and biological substances

0.00

-0.00

0.0

1.1

—

12.15

—

Other salmonella infections, including avohilmo

0.94

-0.00

1.8

1.4

16.00

14.28

pmol/l

—

Recurrent and persistent haematuria

0.00

-0.00

0.0

1.2

—

17.20

—

Pedestrian injured in transport accident

0.94

-0.00

1.3

1.6

13.42

15.24

pmol/l

—

Cleft hard palate NOS

0.00

-0.00

0.0

2.0

—

13.80

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

0.98

-0.00

1.2

1.3

12.20

14.15

pmol/l

—

Unspecified abortion

0.96

-0.00

1.3

1.4

11.60

14.92

pmol/l

—

Inguinal or femoral hernia, bilateral

0.99

-0.00

1.5

13.82

17.87

pmol/l

—

Haematosalpinx/Haematoma of broad ligament

0.00

-0.00

0.0

1.6

—

13.58

—

Other congenital malformations of the digestive system

0.94

-0.00

1.0

1.6

16.00

14.44

pmol/l

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS